| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | deaminase binding | 8.86e-07 | 4 | 122 | 3 | GO:1990827 | |
| GeneOntologyMolecularFunction | N6-methyladenosine-containing RNA reader activity | 1.72e-06 | 15 | 122 | 4 | GO:1990247 | |
| GeneOntologyMolecularFunction | protein-RNA adaptor activity | 1.28e-05 | 24 | 122 | 4 | GO:0140517 | |
| GeneOntologyMolecularFunction | histone binding | 2.26e-04 | 265 | 122 | 8 | GO:0042393 | |
| GeneOntologyMolecularFunction | ribonucleoprotein complex binding | 2.76e-04 | 206 | 122 | 7 | GO:0043021 | |
| GeneOntologyMolecularFunction | telomerase RNA binding | 4.64e-04 | 25 | 122 | 3 | GO:0070034 | |
| GeneOntologyMolecularFunction | chromatin binding | URI1 EED POLE KAT6A CHD7 PAF1 SAFB PBRM1 SUPT6H GLI3 SMARCA2 RERE STAG2 | 5.92e-04 | 739 | 122 | 13 | GO:0003682 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.10e-03 | 127 | 122 | 5 | GO:0008094 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.15e-03 | 262 | 122 | 7 | GO:0140097 | |
| GeneOntologyMolecularFunction | poly(U) RNA binding | 1.16e-03 | 34 | 122 | 3 | GO:0008266 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | DCAF1 DR1 EED KAT6A BAZ1B SRPK2 CHD7 CHRAC1 SRCAP PTMA SAFB PBRM1 UBR5 SUPT6H ATF7IP SMARCA2 SENP6 PHF14 RERE USP15 | 1.41e-06 | 999 | 121 | 20 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromosome organization | HNRNPCL1 KAT6A BAZ1B RFC1 CHMP2B HNRNPCL3 PBRM1 HECW2 ATF7IP SMARCA2 SENP6 LSM14A ZNF830 STAG2 HNRNPCL2 FBXW7 | 2.62e-06 | 686 | 121 | 16 | GO:0051276 |
| GeneOntologyBiologicalProcess | negative regulation of mRNA modification | 3.89e-06 | 6 | 121 | 3 | GO:0090367 | |
| GeneOntologyBiologicalProcess | chromatin organization | DCAF1 EED KAT6A BAZ1B SRPK2 CHD7 CHRAC1 SRCAP PTMA SAFB PBRM1 UBR5 SUPT6H ATF7IP SMARCA2 PHF14 RERE USP15 | 4.81e-06 | 896 | 121 | 18 | GO:0006325 |
| GeneOntologyBiologicalProcess | regulation of mRNA modification | 6.78e-06 | 7 | 121 | 3 | GO:0090365 | |
| GeneOntologyBiologicalProcess | microtubule-based process | BORCS6 SLAIN2 KIF13B CCDC8 CLUAP1 NEK10 TTLL5 CNTRL NCKAP5 CLIP1 CHMP2B TUBB6 DST RP1L1 SENP6 LSM14A PARD3 STAG2 RHOT1 | 1.26e-05 | 1058 | 121 | 19 | GO:0007017 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | SLAIN2 CCDC8 CLUAP1 TTLL5 CNTRL NCKAP5 CLIP1 CHMP2B TUBB6 DST RP1L1 SENP6 LSM14A PARD3 STAG2 | 2.10e-05 | 720 | 121 | 15 | GO:0000226 |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | HNRNPCL1 BAZ1B HNRNPCL3 PBRM1 HECW2 ATF7IP SMARCA2 SENP6 HNRNPCL2 | 2.77e-05 | 266 | 121 | 9 | GO:0033044 |
| GeneOntologyBiologicalProcess | chromatin remodeling | DCAF1 EED KAT6A BAZ1B SRPK2 CHD7 CHRAC1 SRCAP PBRM1 UBR5 SUPT6H ATF7IP SMARCA2 RERE USP15 | 2.93e-05 | 741 | 121 | 15 | GO:0006338 |
| GeneOntologyBiologicalProcess | regulation of organelle organization | SLAIN2 CCDC8 LIMA1 HNRNPCL1 BAZ1B NLGN1 STOX1 CLIP1 CHMP2B HNRNPCL3 MSN PIKFYVE PBRM1 HECW2 ATF7IP SMARCA2 SENP6 HNRNPCL2 RHOT1 FBXW7 | 1.02e-04 | 1342 | 121 | 20 | GO:0033043 |
| GeneOntologyBiologicalProcess | transcription elongation by RNA polymerase II | 1.04e-04 | 127 | 121 | 6 | GO:0006368 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | GCNA DCAF1 PMS1 HNRNPCL1 POLE STOX1 CHRAC1 RFC1 HNRNPCL3 PBRM1 UBR5 SUPT6H SMARCA2 ZNF830 HERC2 HNRNPCL2 FBXW7 | 1.91e-04 | 1081 | 121 | 17 | GO:0006259 |
| GeneOntologyBiologicalProcess | DNA-templated transcription elongation | 2.07e-04 | 144 | 121 | 6 | GO:0006354 | |
| GeneOntologyBiologicalProcess | microtubule bundle formation | 2.15e-04 | 145 | 121 | 6 | GO:0001578 | |
| GeneOntologyBiologicalProcess | RNA export from nucleus | 2.55e-04 | 96 | 121 | 5 | GO:0006405 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | DCAF1 PMS1 DR1 EED HNRNPCL1 LEO1 NELFCD POLE POLR2F BAZ1B CHRAC1 SRCAP PAF1 CHMP2B HNRNPCL3 MFAP1 ZC3H11A PBRM1 POLR3E CEBPZ SUPT6H SMARCA2 ZNF830 RERE HNRNPCL2 | 2.68e-07 | 1377 | 121 | 25 | GO:0140513 |
| GeneOntologyCellularComponent | nucleoplasmic periphery of the nuclear pore complex | 3.74e-06 | 6 | 121 | 3 | GO:1990826 | |
| GeneOntologyCellularComponent | microtubule plus-end | 1.96e-05 | 28 | 121 | 4 | GO:0035371 | |
| GeneOntologyCellularComponent | pronucleus | 1.96e-05 | 28 | 121 | 4 | GO:0045120 | |
| GeneOntologyCellularComponent | transferase complex | DCAF1 DR1 RIOK1 EED LEO1 NEK10 POLE KAT6A POLR2F MARCHF6 CHRAC1 PAF1 STT3B POLR3E WDFY3 PARD3 FBXW7 | 3.99e-05 | 963 | 121 | 17 | GO:1990234 |
| GeneOntologyCellularComponent | microtubule end | 6.77e-05 | 38 | 121 | 4 | GO:1990752 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 2.40e-04 | 96 | 121 | 5 | GO:0070603 | |
| GeneOntologyCellularComponent | fibrillar center | 2.98e-04 | 156 | 121 | 6 | GO:0001650 | |
| GeneOntologyCellularComponent | transcription elongation factor complex | 3.11e-04 | 56 | 121 | 4 | GO:0008023 | |
| GeneOntologyCellularComponent | epsilon DNA polymerase complex | 3.29e-04 | 5 | 121 | 2 | GO:0008622 | |
| GeneOntologyCellularComponent | telomerase holoenzyme complex | 3.96e-04 | 25 | 121 | 3 | GO:0005697 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | BORCS6 DCAF1 DR1 URI1 LEO1 POLE CNTRL KAT6A POLR2F MARCHF6 CHRAC1 PAF1 POLR3E CCDC47 FBXW7 | 4.97e-04 | 972 | 121 | 15 | GO:0140535 |
| GeneOntologyCellularComponent | Cdc73/Paf1 complex | 6.85e-04 | 7 | 121 | 2 | GO:0016593 | |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 7.50e-04 | 335 | 121 | 8 | GO:0061695 | |
| GeneOntologyCellularComponent | ATPase complex | 9.29e-04 | 129 | 121 | 5 | GO:1904949 | |
| GeneOntologyCellularComponent | mitotic spindle | 1.13e-03 | 201 | 121 | 6 | GO:0072686 | |
| GeneOntologyCellularComponent | spindle | 1.69e-03 | 471 | 121 | 9 | GO:0005819 | |
| GeneOntologyCellularComponent | nuclear body | GCNA AMER1 BMP2K KAT6A SRPK2 SRCAP ATF7IP GLI3 SCAPER ZNF830 RERE WDFY3 USP15 | 2.21e-03 | 903 | 121 | 13 | GO:0016604 |
| HumanPheno | Clinodactyly | FAT4 CCDC8 AMER1 POLE BAZ1B CHD7 SRCAP CCDC47 KCNJ5 SCAPER SMARCA2 PACS2 SPRED1 RERE HERC2 STAG2 ZNF292 | 8.90e-06 | 574 | 48 | 17 | HP:0030084 |
| HumanPheno | Radial deviation of the hand or of fingers of the hand | CCDC8 AMER1 BAZ1B CHD7 SRCAP CCDC47 GLI3 SCAPER SMARCA2 PACS2 SPRED1 RERE HERC2 STAG2 ZNF292 | 1.03e-05 | 456 | 48 | 15 | HP:0009485 |
| HumanPheno | Attention deficit hyperactivity disorder | PMS1 POLE BAZ1B CHD7 NLGN1 SRCAP SCAPER SMARCA2 PACS2 SPRED1 RERE HERC2 STAG2 ZNF292 | 1.58e-05 | 413 | 48 | 14 | HP:0007018 |
| HumanPheno | Deviation of the hand or of fingers of the hand | FAT4 CCDC8 AMER1 BAZ1B CHD7 SRCAP CCDC47 GLI3 SCAPER SMARCA2 PACS2 SPRED1 RERE HERC2 STAG2 ZNF292 | 3.13e-05 | 564 | 48 | 16 | HP:0009484 |
| HumanPheno | Radial deviation of finger | CCDC8 AMER1 BAZ1B CHD7 SRCAP CCDC47 SCAPER SMARCA2 PACS2 SPRED1 RERE HERC2 STAG2 ZNF292 | 3.98e-05 | 448 | 48 | 14 | HP:0009466 |
| HumanPheno | Bulbous nose | 8.53e-05 | 201 | 48 | 9 | HP:0000414 | |
| HumanPheno | Clinodactyly of the 5th finger | CCDC8 AMER1 BAZ1B CHD7 SRCAP CCDC47 SCAPER SMARCA2 PACS2 SPRED1 RERE STAG2 ZNF292 | 8.95e-05 | 420 | 48 | 13 | HP:0004209 |
| HumanPheno | Clinodactyly of hands | CCDC8 AMER1 BAZ1B CHD7 SRCAP CCDC47 SCAPER SMARCA2 PACS2 SPRED1 RERE STAG2 ZNF292 | 9.18e-05 | 421 | 48 | 13 | HP:0001157 |
| HumanPheno | Deviation of the 5th finger | CCDC8 AMER1 BAZ1B CHD7 SRCAP CCDC47 SCAPER SMARCA2 PACS2 SPRED1 RERE STAG2 ZNF292 | 9.18e-05 | 421 | 48 | 13 | HP:0009179 |
| HumanPheno | Triangular face | 1.39e-04 | 167 | 48 | 8 | HP:0000325 | |
| HumanPheno | Abnormal 5th finger morphology | CCDC8 AMER1 BAZ1B CHD7 SRCAP CCDC47 GLI3 SCAPER SMARCA2 PACS2 SPRED1 RERE STAG2 ZNF292 | 1.61e-04 | 509 | 48 | 14 | HP:0004207 |
| HumanPheno | Finger clinodactyly | CCDC8 AMER1 BAZ1B CHD7 SRCAP CCDC47 SCAPER SMARCA2 PACS2 SPRED1 RERE STAG2 ZNF292 | 1.89e-04 | 452 | 48 | 13 | HP:0040019 |
| HumanPheno | Short attention span | PMS1 POLE BAZ1B CHD7 NLGN1 SRCAP SCAPER SMARCA2 PACS2 SPRED1 RERE HERC2 STAG2 ZNF292 | 1.91e-04 | 517 | 48 | 14 | HP:0000736 |
| HumanPheno | Enlarged joints | 2.10e-04 | 13 | 48 | 3 | HP:0003037 | |
| HumanPheno | Disinhibition | PMS1 FAT4 POLE BAZ1B CHD7 NLGN1 SRCAP CHMP2B HECW2 GLI3 SCAPER SMARCA2 PACS2 SPRED1 RERE HERC2 STAG2 ZNF292 | 2.13e-04 | 807 | 48 | 18 | HP:0000734 |
| HumanPheno | Inappropriate behavior | PMS1 FAT4 POLE BAZ1B CHD7 NLGN1 SRCAP CHMP2B HECW2 GLI3 SCAPER SMARCA2 PACS2 SPRED1 RERE HERC2 STAG2 ZNF292 | 2.13e-04 | 807 | 48 | 18 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | PMS1 FAT4 POLE BAZ1B CHD7 NLGN1 SRCAP CHMP2B HECW2 GLI3 SCAPER SMARCA2 PACS2 SPRED1 RERE HERC2 STAG2 ZNF292 | 2.13e-04 | 807 | 48 | 18 | HP:5200123 |
| HumanPheno | Social disinhibition | PMS1 FAT4 POLE BAZ1B CHD7 NLGN1 SRCAP CHMP2B HECW2 GLI3 SCAPER SMARCA2 PACS2 SPRED1 RERE HERC2 STAG2 ZNF292 | 2.13e-04 | 807 | 48 | 18 | HP:5200029 |
| HumanPheno | Reduced attention regulation | PMS1 POLE BAZ1B CHD7 NLGN1 SRCAP SCAPER SMARCA2 PACS2 SPRED1 RERE HERC2 STAG2 ZNF292 | 2.29e-04 | 526 | 48 | 14 | HP:5200044 |
| HumanPheno | Abnormal thought pattern | KAT6A BAZ1B CHD7 NLGN1 SRCAP CHMP2B HECW2 SMARCA2 PACS2 RERE HERC2 USP48 | 2.64e-04 | 404 | 48 | 12 | HP:5200269 |
| HumanPheno | Deviation of finger | CCDC8 AMER1 BAZ1B CHD7 SRCAP CCDC47 SCAPER SMARCA2 PACS2 SPRED1 RERE HERC2 STAG2 ZNF292 | 2.85e-04 | 537 | 48 | 14 | HP:0004097 |
| HumanPheno | Abnormality of the chin | CCDC8 EED KAT6A BAZ1B CHD7 SRCAP DST SMARCA2 RERE HERC2 STAG2 ZNF292 | 2.96e-04 | 409 | 48 | 12 | HP:0000306 |
| Domain | hnRNP_C | 5.10e-06 | 6 | 120 | 3 | IPR017347 | |
| Domain | Bromodomain_CS | 2.17e-05 | 26 | 120 | 4 | IPR018359 | |
| Domain | BROMODOMAIN_1 | 9.09e-05 | 37 | 120 | 4 | PS00633 | |
| Domain | Bromodomain | 1.01e-04 | 38 | 120 | 4 | PF00439 | |
| Domain | BROMODOMAIN_2 | 1.37e-04 | 41 | 120 | 4 | PS50014 | |
| Domain | Bromodomain | 1.50e-04 | 42 | 120 | 4 | IPR001487 | |
| Domain | BROMO | 1.50e-04 | 42 | 120 | 4 | SM00297 | |
| Domain | - | 1.50e-04 | 42 | 120 | 4 | 1.20.920.10 | |
| Domain | HSA | 2.44e-04 | 4 | 120 | 2 | SM00573 | |
| Domain | HSA | 2.44e-04 | 4 | 120 | 2 | PS51204 | |
| Domain | HSA_dom | 2.44e-04 | 4 | 120 | 2 | IPR014012 | |
| Domain | HSA | 2.44e-04 | 4 | 120 | 2 | PF07529 | |
| Domain | TSP_3 | 4.04e-04 | 5 | 120 | 2 | PF02412 | |
| Domain | TSP3 | 4.04e-04 | 5 | 120 | 2 | PS51234 | |
| Domain | TSP_CTER | 4.04e-04 | 5 | 120 | 2 | PS51236 | |
| Domain | Thrombospondin_3_rpt | 4.04e-04 | 5 | 120 | 2 | IPR017897 | |
| Domain | TSP_type-3_rpt | 4.04e-04 | 5 | 120 | 2 | IPR028974 | |
| Domain | - | 4.04e-04 | 5 | 120 | 2 | 4.10.1080.10 | |
| Domain | Thrombospondin_C | 4.04e-04 | 5 | 120 | 2 | IPR008859 | |
| Domain | TSP_C | 4.04e-04 | 5 | 120 | 2 | PF05735 | |
| Domain | Thrombospondin_3-like_rpt | 4.04e-04 | 5 | 120 | 2 | IPR003367 | |
| Domain | BRK | 6.04e-04 | 6 | 120 | 2 | SM00592 | |
| Domain | BRK_domain | 6.04e-04 | 6 | 120 | 2 | IPR006576 | |
| Domain | BRK | 6.04e-04 | 6 | 120 | 2 | PF07533 | |
| Domain | HECT | 6.76e-04 | 27 | 120 | 3 | PF00632 | |
| Domain | HECTc | 6.76e-04 | 27 | 120 | 3 | SM00119 | |
| Domain | HECT_dom | 6.76e-04 | 27 | 120 | 3 | IPR000569 | |
| Domain | HECT | 6.76e-04 | 27 | 120 | 3 | PS50237 | |
| Domain | DUSP | 8.42e-04 | 7 | 120 | 2 | PS51283 | |
| Domain | - | 8.42e-04 | 7 | 120 | 2 | 3.30.2230.10 | |
| Domain | Pept_C19_DUSP | 8.42e-04 | 7 | 120 | 2 | IPR006615 | |
| Domain | CBFD_NFYB_HMF | 1.12e-03 | 8 | 120 | 2 | PF00808 | |
| Domain | CBFA_NFYB_domain | 1.12e-03 | 8 | 120 | 2 | IPR003958 | |
| Domain | SNF2_N | 1.12e-03 | 32 | 120 | 3 | IPR000330 | |
| Domain | SNF2_N | 1.12e-03 | 32 | 120 | 3 | PF00176 | |
| Domain | CAP_GLY | 1.78e-03 | 10 | 120 | 2 | PF01302 | |
| Domain | CAP_GLY | 1.78e-03 | 10 | 120 | 2 | SM01052 | |
| Domain | - | 1.78e-03 | 10 | 120 | 2 | 2.30.30.190 | |
| Domain | CAP_GLY_1 | 1.78e-03 | 10 | 120 | 2 | PS00845 | |
| Domain | CAP_GLY_2 | 1.78e-03 | 10 | 120 | 2 | PS50245 | |
| Domain | CAP-Gly_domain | 1.78e-03 | 10 | 120 | 2 | IPR000938 | |
| Domain | BAH | 2.17e-03 | 11 | 120 | 2 | PS51038 | |
| Domain | BAH_dom | 2.17e-03 | 11 | 120 | 2 | IPR001025 | |
| Domain | BAH | 2.17e-03 | 11 | 120 | 2 | SM00439 | |
| Domain | BAH | 2.17e-03 | 11 | 120 | 2 | PF01426 | |
| Domain | Znf_FYVE_PHD | 2.60e-03 | 147 | 120 | 5 | IPR011011 | |
| Domain | - | 3.29e-03 | 95 | 120 | 4 | 2.60.120.200 | |
| Domain | SANT | 4.07e-03 | 50 | 120 | 3 | SM00717 | |
| Domain | SANT/Myb | 4.55e-03 | 52 | 120 | 3 | IPR001005 | |
| Domain | Helicase_C | 5.03e-03 | 107 | 120 | 4 | PF00271 | |
| Domain | HELICc | 5.03e-03 | 107 | 120 | 4 | SM00490 | |
| Domain | Helicase_C | 5.20e-03 | 108 | 120 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 5.37e-03 | 109 | 120 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 5.37e-03 | 109 | 120 | 4 | PS51192 | |
| Domain | DEXDc | 5.37e-03 | 109 | 120 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 5.54e-03 | 110 | 120 | 4 | IPR014001 | |
| Domain | Laminin_G | 6.17e-03 | 58 | 120 | 3 | IPR001791 | |
| Pathway | REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX | 3.90e-05 | 58 | 93 | 5 | M805 | |
| Pathway | REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX | 4.24e-05 | 59 | 93 | 5 | MM14504 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS | 1.93e-04 | 81 | 93 | 5 | M865 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS | 2.17e-04 | 83 | 93 | 5 | MM15314 | |
| Pubmed | SLAIN2 SFSWAP BMP2K RBM33 BMS1 BAZ1B SRPK2 CHD7 ZFC3H1 STRIP1 STT3B TUBB6 ZC3H11A PBRM1 DST MDN1 CEBPZ CCDC47 SUPT6H NMT2 SMARCA2 OSBPL8 GOLIM4 PHF14 LSM14A EIF3C DNAJC1 HERC2 PARD3 STAG2 | 6.46e-15 | 1497 | 123 | 30 | 31527615 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | DR1 EED LEO1 SFSWAP POLR2F BAZ1B CHD7 ZFC3H1 CHRAC1 RFC1 SRCAP PAF1 ZBTB14 STT3B MFAP1 ZC3H11A SAFB ZBTB39 PBRM1 DST MDN1 POLR3E CEBPZ SUPT6H PHF14 DNAJC1 STAG2 | 7.13e-14 | 1294 | 123 | 27 | 30804502 |
| Pubmed | KIF13B DR1 LIMA1 AMER1 HNRNPCL1 LEO1 NELFCD CNTRL ZFC3H1 STOX1 SRCAP STT3B HNRNPCL3 MSN GPALPP1 MFAP1 C9orf43 SAFB DST MDN1 CEBPZ CCDC47 PHF14 LSM14A STAG2 HNRNPCL2 ZNF292 | 9.08e-13 | 1442 | 123 | 27 | 35575683 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | LIMA1 LEO1 SFSWAP BAZ1B CHD7 RFC1 CLIP1 STRIP1 MFAP1 ZC3H11A SAFB MDN1 SMARCA2 SENP6 PACS2 PHF14 EIF3C RERE PARD3 STAG2 | 4.10e-12 | 774 | 123 | 20 | 15302935 |
| Pubmed | POLE BMS1 BAZ1B CHD7 RFC1 BIRC6 MSN ZC3H11A PBRM1 DST MDN1 UBR5 CEBPZ SUPT6H SMARCA2 OSBPL8 HERC2 STAG2 | 1.88e-11 | 653 | 123 | 18 | 22586326 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | CCDC8 EED IPO8 POLE KAT6A BMS1 BAZ1B SRPK2 ZFC3H1 RFC1 BIRC6 CHMP2B ZC3H11A PBRM1 MDN1 CEBPZ SCAPER LSM14A HERC2 | 2.56e-11 | 759 | 123 | 19 | 35915203 |
| Pubmed | DCAF1 SLAIN2 SFSWAP P3H3 KAT6A BAZ1B SRPK2 SRCAP PTMA TUBB6 MFAP1 PBRM1 UBR5 GLI3 SCN5A SCAPER SMARCA2 RERE WDFY3 PARD3 RHOT1 BRWD1 | 5.93e-11 | 1116 | 123 | 22 | 31753913 | |
| Pubmed | DCAF1 PMS1 CCDC8 EED IPO8 POLE TTLL5 BMS1 BAZ1B SRPK2 ZFC3H1 PAF1 STT3B TUBB6 MFAP1 MDN1 UBR5 CEBPZ CCDC47 SUPT6H OSBPL8 DNAJC1 HERC2 PARD3 USP48 | 7.18e-11 | 1487 | 123 | 25 | 33957083 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DCAF1 POLE BMS1 BAZ1B VTA1 CHD7 RFC1 SRCAP BIRC6 MSN TUBB6 MFAP1 ZC3H11A SAFB DST MDN1 UBR5 CEBPZ CCDC47 SMARCA2 WDFY3 HERC2 PARD3 | 3.75e-10 | 1353 | 123 | 23 | 29467282 |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | HNRNPCL1 RBM33 NCKAP5 CHD7 SRCAP BIRC6 HNRNPCL3 PTMA PBRM1 DST MDN1 STAG2 HNRNPCL2 | 6.16e-10 | 363 | 123 | 13 | 14691545 |
| Pubmed | CCDC8 LIMA1 RBM33 BMS1 BAZ1B CHD7 RFC1 SRCAP ZBTB14 PTMA MSN MFAP1 PBRM1 DST ATF7IP GLI3 SMARCA2 LSM14A EIF3C RERE HERC2 RHOT1 FBXW7 | 1.07e-09 | 1429 | 123 | 23 | 35140242 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PMS1 HNRNPCL1 SFSWAP RBM33 BAZ1B CHD7 RFC1 PAF1 HNRNPCL3 MFAP1 ZC3H11A SAFB CEBPZ ATF7IP SENP6 PHF14 ZNF830 STAG2 HNRNPCL2 | 1.18e-09 | 954 | 123 | 19 | 36373674 |
| Pubmed | EED LEO1 NELFCD POLE BAZ1B RFC1 PAF1 MSN MFAP1 ZC3H11A SAFB PBRM1 MDN1 UBR5 SUPT6H SMARCA2 PHF14 USP48 STAG2 | 3.18e-09 | 1014 | 123 | 19 | 32416067 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | LEO1 SFSWAP BMS1 BAZ1B RFC1 PAF1 MFAP1 SAFB PBRM1 MDN1 CEBPZ SUPT6H SMARCA2 PHF14 EIF3C | 4.24e-09 | 605 | 123 | 15 | 28977666 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | PMS1 EED KAT6A BAZ1B CHD7 RFC1 SRCAP PBRM1 SENP6 PHF14 HERC2 USP48 STAG2 ZNF292 BRWD1 | 4.53e-09 | 608 | 123 | 15 | 36089195 |
| Pubmed | DCAF1 LEO1 CHD7 PAF1 MFAP1 THBS1 MDN1 UBR5 GLI3 SMARCA2 USP15 | 5.66e-09 | 282 | 123 | 11 | 23667531 | |
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 7.28e-09 | 163 | 123 | 9 | 22113938 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | DR1 LIMA1 LEO1 POLR2F SRPK2 SRCAP PAF1 CLIP1 STT3B MSN PBRM1 MDN1 SUPT6H SCAPER SMARCA2 EIF3C BRWD1 | 8.51e-09 | 847 | 123 | 17 | 35235311 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | IPO8 BMP2K NELFCD RBM33 POLE TTLL5 BMS1 SRPK2 VTA1 BIRC6 STRIP1 STT3B CHMP2B PIKFYVE DST MDN1 CCDC47 OSBPL8 DNAJC1 RERE HERC2 RHOT1 | 1.33e-08 | 1496 | 123 | 22 | 32877691 |
| Pubmed | SLAIN2 FAT4 CCDC8 AMER1 SFSWAP BMP2K CNTRL BMS1 BIRC6 STRIP1 ZC3H11A DST UBR5 ATF7IP GLI3 PARD3 | 1.70e-08 | 777 | 123 | 16 | 35844135 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | PMS1 LIMA1 RIOK1 BAZ1B RFC1 SRCAP PAF1 CHMP2B PTMA GPALPP1 ZC3H11A SAFB DST ATF7IP SENP6 LSM14A EIF3C | 3.53e-08 | 934 | 123 | 17 | 33916271 |
| Pubmed | DR1 RIOK1 RBM33 CHD7 BIRC6 STRIP1 STT3B CHMP2B PIKFYVE MFAP1 CEBPZ CCDC47 OSBPL8 DNAJC1 USP15 | 5.33e-08 | 733 | 123 | 15 | 34672954 | |
| Pubmed | KIF13B LIMA1 SRPK2 CHD7 PAF1 CLIP1 STRIP1 MSN TUBB6 PBRM1 DST MDN1 UBR5 ATF7IP WDFY3 HERC2 PARD3 | 5.48e-08 | 963 | 123 | 17 | 28671696 | |
| Pubmed | LIMA1 SFSWAP BMS1 BAZ1B SRPK2 ZFC3H1 RFC1 TUBB6 MFAP1 ZC3H11A SAFB PBRM1 MDN1 CEBPZ LSM14A EIF3C | 5.57e-08 | 847 | 123 | 16 | 35850772 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | CCDC8 SRPK2 ZFC3H1 SRCAP TUBB6 PBRM1 UBR5 CEBPZ SUPT6H SMARCA2 HERC2 USP15 | 5.88e-08 | 440 | 123 | 12 | 34244565 |
| Pubmed | 6.52e-08 | 210 | 123 | 9 | 16565220 | ||
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 6.72e-08 | 150 | 123 | 8 | 28242625 | |
| Pubmed | 9.57e-08 | 157 | 123 | 8 | 30186101 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CCDC8 LIMA1 BAZ1B SRCAP TUBB6 MFAP1 ZC3H11A SAFB PBRM1 DST MDN1 UBR5 CEBPZ SUPT6H EIF3C HERC2 STAG2 | 1.31e-07 | 1024 | 123 | 17 | 24711643 |
| Pubmed | 1.72e-07 | 4 | 123 | 3 | 36681355 | ||
| Pubmed | 1.72e-07 | 4 | 123 | 3 | 23831410 | ||
| Pubmed | hnRNP C is required for postimplantation mouse development but Is dispensable for cell viability. | 1.72e-07 | 4 | 123 | 3 | 10805751 | |
| Pubmed | hnRNPC induces isoform shifts in miR-21-5p leading to cancer development. | 1.72e-07 | 4 | 123 | 3 | 35729324 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | KIF13B LEO1 RBM33 ANKRD49 BAZ1B CHD7 SRCAP PAF1 PIKFYVE UBR5 SUPT6H ATF7IP SENP6 | 1.82e-07 | 588 | 123 | 13 | 38580884 |
| Pubmed | SLAIN2 KIF13B HNRNPCL1 SFSWAP RBM33 BMS1 SRPK2 HNRNPCL3 ZC3H11A DST ZNF830 EIF3C HNRNPCL2 FBXW7 | 2.98e-07 | 723 | 123 | 14 | 34133714 | |
| Pubmed | Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3. | LIMA1 HNRNPCL1 CHD7 ZFC3H1 HNRNPCL3 PTMA ZBTB39 PHF14 HNRNPCL2 ZNF292 | 3.17e-07 | 332 | 123 | 10 | 30595499 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 3.17e-07 | 332 | 123 | 10 | 32786267 | |
| Pubmed | A method to identify cDNAs based on localization of green fluorescent protein fusion products. | 3.42e-07 | 17 | 123 | 4 | 10716735 | |
| Pubmed | 3.65e-07 | 187 | 123 | 8 | 26460568 | ||
| Pubmed | 3.89e-07 | 79 | 123 | 6 | 14729942 | ||
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 29846695 | ||
| Pubmed | Structural basis for evolutionarily conserved interactions between TFIIS and Paf1C. | 4.29e-07 | 5 | 123 | 3 | 37696373 | |
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 9128719 | ||
| Pubmed | Evaluating the role of hnRNP-C and FMRP in the cAMP-induced APP metabolism. | 4.29e-07 | 5 | 123 | 3 | 25809670 | |
| Pubmed | 4.39e-07 | 18 | 123 | 4 | 29507117 | ||
| Pubmed | SECISBP2L PMS1 RIOK1 HNRNPCL1 LEO1 POLE SRPK2 HNRNPCL3 MSN TUBB6 DST HNRNPCL4 RHOT1 | 5.65e-07 | 650 | 123 | 13 | 38777146 | |
| Pubmed | LEO1 CNST TTLL5 ANKRD49 SRPK2 NCKAP5 ZFC3H1 THBS1 DST NMT2 OSBPL8 SENP6 SPRED1 EIF3C WDFY3 HERC2 ZNF292 BRWD1 | 6.54e-07 | 1285 | 123 | 18 | 35914814 | |
| Pubmed | 8.57e-07 | 6 | 123 | 3 | 26048669 | ||
| Pubmed | Selective disruption of genes expressed in totipotent embryonal stem cells. | 8.57e-07 | 6 | 123 | 3 | 1317320 | |
| Pubmed | 8.57e-07 | 6 | 123 | 3 | 15687492 | ||
| Pubmed | 8.57e-07 | 6 | 123 | 3 | 18363099 | ||
| Pubmed | EED POLE CHD7 RFC1 BIRC6 C9orf43 ZC3H11A PBRM1 CEBPZ SUPT6H PHF14 | 9.48e-07 | 469 | 123 | 11 | 27634302 | |
| Pubmed | Scanning the human proteome for calmodulin-binding proteins. | 9.62e-07 | 92 | 123 | 6 | 15840729 | |
| Pubmed | PMS1 DR1 URI1 BAZ1B CHRAC1 SRCAP PAF1 PBRM1 GLI3 SCAPER SMARCA2 PHF14 ZNF830 ZNF292 | 1.11e-06 | 808 | 123 | 14 | 20412781 | |
| Pubmed | 1.48e-06 | 99 | 123 | 6 | 34161765 | ||
| Pubmed | 1.50e-06 | 7 | 123 | 3 | 25846207 | ||
| Pubmed | SECISBP2L KIF13B ZFC3H1 BIRC6 GPALPP1 PPP1R26 PIKFYVE ZBTB39 SCAPER OSBPL8 PHF14 | 1.54e-06 | 493 | 123 | 11 | 15368895 | |
| Pubmed | SLAIN2 PAF1 BIRC6 CLIP1 MSN DST SUPT6H SPRED1 EIF3C PARD3 STAG2 | 1.66e-06 | 497 | 123 | 11 | 23414517 | |
| Pubmed | RIOK1 AMER1 CHRAC1 RFC1 BIRC6 THBS2 UBR5 OSBPL8 HERC2 PARD3 USP48 USP15 | 1.69e-06 | 604 | 123 | 12 | 38803224 | |
| Pubmed | SLAIN2 IPO8 RBM33 CHD7 RFC1 PAF1 MSN GPALPP1 ZC3H11A SAFB ZBTB39 UBR5 SMARCA2 LSM14A STAG2 ZNF292 | 1.85e-06 | 1103 | 123 | 16 | 34189442 | |
| Pubmed | URI1 P3H3 NELFCD POLR2F BMS1 SRPK2 RFC1 SAFB SUPT6H SMARCA2 EIF3C USP15 | 2.03e-06 | 615 | 123 | 12 | 31048545 | |
| Pubmed | 2.59e-06 | 61 | 123 | 5 | 20305087 | ||
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 2.85e-06 | 330 | 123 | 9 | 33301849 | |
| Pubmed | FAT4 MXRA5 POLE CHD7 RFC1 THBS1 PBRM1 MDN1 CCDC47 SMARCA2 WDFY3 STAG2 | 2.96e-06 | 638 | 123 | 12 | 31182584 | |
| Pubmed | 3.32e-06 | 251 | 123 | 8 | 28077445 | ||
| Pubmed | 3.57e-06 | 9 | 123 | 3 | 10452948 | ||
| Pubmed | 3.57e-06 | 9 | 123 | 3 | 15923622 | ||
| Pubmed | CNST NELFCD CNTRL MARCHF6 APOBR BIRC6 STT3B MDN1 UBR5 CCDC47 OSBPL8 GOLIM4 DNAJC1 HERC2 STAG2 RHOT1 | 3.85e-06 | 1168 | 123 | 16 | 19946888 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | RIOK1 BMP2K BMS1 BAZ1B CHD7 RFC1 PAF1 GPALPP1 TUBB6 MFAP1 SAFB PBRM1 MDN1 CEBPZ CCDC47 SMARCA2 OSBPL8 | 4.16e-06 | 1318 | 123 | 17 | 30463901 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | SECISBP2L SLAIN2 URI1 RIOK1 AMER1 LEO1 BMP2K RBM33 PAF1 CHMP2B GPALPP1 MFAP1 UBR5 LSM14A EIF3C | 4.18e-06 | 1038 | 123 | 15 | 26673895 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | SECISBP2L DCAF1 KIF13B CCDC8 LIMA1 CLUAP1 URI1 RIOK1 AMER1 IPO8 LEO1 CLIP1 STT3B MFAP1 GLI3 PARD3 USP15 | 4.29e-06 | 1321 | 123 | 17 | 27173435 |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | DCAF1 IPO8 BMP2K RBM33 BAZ1B ZFC3H1 STRIP1 STT3B SAFB PBRM1 CEBPZ GLI3 OSBPL8 GOLIM4 DNAJC1 RERE | 5.58e-06 | 1203 | 123 | 16 | 29180619 |
| Pubmed | 5.60e-06 | 191 | 123 | 7 | 31177093 | ||
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 5.89e-06 | 361 | 123 | 9 | 30344098 | |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 7.22e-06 | 130 | 123 | 6 | 35545047 | |
| Pubmed | 7.22e-06 | 75 | 123 | 5 | 25593309 | ||
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | LIMA1 RIOK1 SFSWAP POLE CHD7 RFC1 PAF1 ZBTB39 POLR3E LSM14A EIF3C | 7.58e-06 | 583 | 123 | 11 | 29844126 |
| Pubmed | 7.59e-06 | 281 | 123 | 8 | 24163370 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 7.79e-06 | 475 | 123 | 10 | 31040226 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 7.99e-06 | 283 | 123 | 8 | 30585729 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | KIF13B POLE BAZ1B VTA1 BIRC6 TUBB6 UBR5 CEBPZ CCDC47 SMARCA2 EIF3C RHOT1 | 8.01e-06 | 704 | 123 | 12 | 29955894 |
| Pubmed | Interaction between nucleosome assembly protein 1-like family members. | 9.28e-06 | 12 | 123 | 3 | 21333655 | |
| Pubmed | The biogenesis of the coiled body during early mouse development. | 9.28e-06 | 12 | 123 | 3 | 7768196 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | LIMA1 BMS1 BAZ1B SRPK2 ZFC3H1 RFC1 STT3B MSN TUBB6 MFAP1 THBS1 ZC3H11A SAFB DST CEBPZ LSM14A | 9.65e-06 | 1257 | 123 | 16 | 36526897 |
| Pubmed | Docking motif-guided mapping of the interactome of protein phosphatase-1. | 9.91e-06 | 80 | 123 | 5 | 19389623 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | URI1 RIOK1 LEO1 SRPK2 RFC1 PAF1 BIRC6 MSN TUBB6 UBR5 CEBPZ CCDC47 SUPT6H OSBPL8 GOLIM4 EIF3C STAG2 | 1.05e-05 | 1415 | 123 | 17 | 28515276 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | SLAIN2 RIOK1 AMER1 IPO8 BMP2K TTLL5 CNTRL CLIP1 TUBB6 UBR5 HERC2 USP15 BRWD1 | 1.09e-05 | 853 | 123 | 13 | 28718761 |
| Pubmed | FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells. | 1.11e-05 | 212 | 123 | 7 | 33462405 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | DCAF1 SFSWAP BMS1 BAZ1B RFC1 PAF1 TUBB6 ZC3H11A SAFB MDN1 CEBPZ SUPT6H PHF14 EIF3C | 1.13e-05 | 989 | 123 | 14 | 36424410 |
| Pubmed | SFSWAP BMS1 SRPK2 ZFC3H1 PTMA MFAP1 ZC3H11A SAFB CEBPZ LSM14A ZNF830 EIF3C | 1.17e-05 | 731 | 123 | 12 | 29298432 | |
| Pubmed | Induced thrombospondin expression in the mouse pancreas during pancreatic injury. | 1.24e-05 | 2 | 123 | 2 | 16181801 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 17620335 | ||
| Pubmed | Human cytomegalovirus infection modulates thrombospondins 1 and 2 in primary fetal astrocytes. | 1.24e-05 | 2 | 123 | 2 | 23660684 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 39122122 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 34425286 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 33073945 | ||
| Pubmed | Thrombospondin-1 (TSP1)-null and TSP2-null mice exhibit lower intraocular pressures. | 1.24e-05 | 2 | 123 | 2 | 22930728 | |
| Pubmed | Modulation of thrombospondin expression during differentiation of embryonal carcinoma cells. | 1.24e-05 | 2 | 123 | 2 | 8126073 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 38339060 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 33372257 | ||
| Interaction | POLR1G interactions | URI1 LEO1 KAT6A POLR2F BMS1 CHD7 ZFC3H1 RFC1 SRCAP PAF1 MFAP1 PBRM1 MDN1 POLR3E CEBPZ SUPT6H ATF7IP PHF14 USP48 STAG2 ZNF292 | 1.99e-12 | 489 | 123 | 21 | int:POLR1G |
| Interaction | ZNF330 interactions | RIOK1 IPO8 LEO1 POLE BMS1 BAZ1B SRPK2 CHD7 ZFC3H1 RFC1 PAF1 MFAP1 PBRM1 CEBPZ SUPT6H SENP6 PHF14 USP48 STAG2 ZNF292 | 3.22e-12 | 446 | 123 | 20 | int:ZNF330 |
| Interaction | CENPA interactions | DR1 LEO1 POLE KAT6A BMS1 BAZ1B CHD7 RFC1 PBRM1 CEBPZ CCDC47 SMARCA2 SENP6 PHF14 USP48 STAG2 ZNF292 BRWD1 | 1.54e-11 | 377 | 123 | 18 | int:CENPA |
| Interaction | TERF2IP interactions | PMS1 EED LEO1 SFSWAP ANKRD49 CHD7 RFC1 SRCAP PAF1 CHMP2B PTMA MFAP1 ZC3H11A SUPT6H ATF7IP SENP6 ZNF830 WDFY3 USP48 ZNF292 | 1.47e-10 | 552 | 123 | 20 | int:TERF2IP |
| Interaction | NUP43 interactions | DCAF1 DR1 LEO1 BMS1 ZFC3H1 RFC1 SRCAP PAF1 GPALPP1 MFAP1 SAFB PBRM1 DST UBR5 CEBPZ SUPT6H ATF7IP SENP6 RERE ZNF292 | 1.28e-09 | 625 | 123 | 20 | int:NUP43 |
| Interaction | TOP1 interactions | DCAF1 PMS1 EED LEO1 POLE KAT6A BAZ1B SRPK2 CHRAC1 RFC1 SRCAP PAF1 MFAP1 ZC3H11A SAFB PBRM1 UBR5 SUPT6H PHF14 HERC2 FBXW7 | 1.35e-09 | 696 | 123 | 21 | int:TOP1 |
| Interaction | PARP1 interactions | CCDC8 DR1 EED LEO1 POLE BMS1 BAZ1B CHD7 CHRAC1 RFC1 SRCAP PAF1 STT3B MFAP1 C9orf43 PBRM1 MDN1 CEBPZ SUPT6H SMARCA2 SENP6 PHF14 EIF3C USP48 USP15 STAG2 ZNF292 | 1.97e-08 | 1316 | 123 | 27 | int:PARP1 |
| Interaction | NUP50 interactions | PMS1 SFSWAP NELFCD RBM33 SRPK2 CHD7 RFC1 GPALPP1 MFAP1 PBRM1 SUPT6H SENP6 ZNF830 ZNF292 | 2.21e-08 | 341 | 123 | 14 | int:NUP50 |
| Interaction | POLR1E interactions | URI1 LEO1 POLR2F BMS1 CHD7 ZFC3H1 SRCAP PAF1 MFAP1 PBRM1 MDN1 POLR3E CEBPZ ZNF292 | 3.07e-08 | 350 | 123 | 14 | int:POLR1E |
| Interaction | CHD4 interactions | CCDC8 EED LEO1 SFSWAP KAT6A BMS1 BAZ1B RFC1 PAF1 BIRC6 CLIP1 MFAP1 SAFB PBRM1 MDN1 SUPT6H SMARCA2 PHF14 EIF3C USP15 HNRNPCL2 FBXW7 | 5.04e-08 | 938 | 123 | 22 | int:CHD4 |
| Interaction | CSNK2A1 interactions | CCDC8 RIOK1 LEO1 RBM33 KAT6A POLR2F BMS1 ZFC3H1 PAF1 BIRC6 MFAP1 SAFB DST POLR3E SUPT6H HECW2 NMT2 PPP1R1B OSBPL8 LSM14A EIF3C USP48 | 7.04e-08 | 956 | 123 | 22 | int:CSNK2A1 |
| Interaction | HECTD1 interactions | CCDC8 EED IPO8 SFSWAP POLE KAT6A BMS1 BAZ1B SRPK2 ZFC3H1 RFC1 BIRC6 CHMP2B ZC3H11A PBRM1 MDN1 CEBPZ SCAPER LSM14A HERC2 USP15 FBXW7 | 1.16e-07 | 984 | 123 | 22 | int:HECTD1 |
| Interaction | SUMO2 interactions | GCNA RIOK1 BAZ1B SRCAP PAF1 PTMA TUBB6 ZC3H11A SAFB ZBTB39 PBRM1 DST MDN1 ATF7IP SENP6 USP48 STAG2 | 1.16e-07 | 591 | 123 | 17 | int:SUMO2 |
| Interaction | H3C1 interactions | DCAF1 FAT4 RIOK1 EED LEO1 KAT6A BAZ1B CHD7 RFC1 SRCAP PAF1 PIKFYVE THBS1 PBRM1 SMARCA2 SENP6 ZNF830 EIF3C USP48 STAG2 ZNF292 | 1.18e-07 | 901 | 123 | 21 | int:H3C1 |
| Interaction | SIRT7 interactions | DCAF1 POLE BMS1 BAZ1B CHD7 RFC1 BIRC6 MSN ZC3H11A PBRM1 DST MDN1 UBR5 CEBPZ SUPT6H SMARCA2 OSBPL8 HERC2 STAG2 | 1.26e-07 | 744 | 123 | 19 | int:SIRT7 |
| Interaction | SSRP1 interactions | EED LEO1 POLE KAT6A ZFC3H1 CHRAC1 RFC1 PAF1 ZC3H11A SAFB PBRM1 UBR5 POLR3E SUPT6H PHF14 ZNF830 FBXW7 BRWD1 | 1.84e-07 | 685 | 123 | 18 | int:SSRP1 |
| Interaction | CEP250 interactions | BORCS6 DCAF1 CCDC8 AMER1 CLIP1 PTMA MSN DST UBR5 SUPT6H ATF7IP HERC2 | 1.95e-07 | 287 | 123 | 12 | int:CEP250 |
| Interaction | H2BC8 interactions | RIOK1 EED BMS1 BAZ1B CHD7 RFC1 SRCAP PTMA GPALPP1 PBRM1 CCDC47 SENP6 PHF14 USP48 STAG2 ZNF292 | 4.52e-07 | 576 | 123 | 16 | int:H2BC8 |
| Interaction | PPP1CC interactions | SECISBP2L LIMA1 URI1 EED LEO1 BMP2K CNST GRXCR1 ZFC3H1 PAF1 UBR5 POLR3E CEBPZ SUPT6H NMT2 PPP1R1B USP48 FBXW7 | 5.46e-07 | 738 | 123 | 18 | int:PPP1CC |
| Interaction | H1-2 interactions | DCAF1 FAT4 RIOK1 EED HNRNPCL1 LEO1 NELFCD CNTRL KAT6A BMS1 BAZ1B ZFC3H1 PAF1 ZC3H11A DST CEBPZ USP48 | 6.23e-07 | 666 | 123 | 17 | int:H1-2 |
| Interaction | APEX1 interactions | DR1 EED BMP2K NELFCD KAT6A BMS1 BAZ1B SRPK2 CHD7 RFC1 SRCAP PAF1 ZBTB14 MSN MFAP1 SAFB PBRM1 CEBPZ LSM14A USP48 STAG2 RHOT1 ZNF292 BRWD1 | 6.33e-07 | 1271 | 123 | 24 | int:APEX1 |
| Interaction | H3-3A interactions | DCAF1 PMS1 RIOK1 EED KAT6A BAZ1B CHD7 RFC1 SRCAP PBRM1 SENP6 PHF14 HERC2 USP48 USP15 STAG2 ZNF292 BRWD1 | 6.76e-07 | 749 | 123 | 18 | int:H3-3A |
| Interaction | CHD3 interactions | CCDC8 RIOK1 EED SFSWAP KAT6A BAZ1B RFC1 CLIP1 SAFB PBRM1 MDN1 CEBPZ SUPT6H SMARCA2 PHF14 EIF3C STAG2 HNRNPCL2 | 7.88e-07 | 757 | 123 | 18 | int:CHD3 |
| Interaction | HNRNPCL2 interactions | PMS1 EED HNRNPCL1 P3H3 BAZ1B RFC1 PAF1 HNRNPCL3 ZC3H11A PBRM1 HNRNPCL2 | 9.64e-07 | 274 | 123 | 11 | int:HNRNPCL2 |
| Interaction | SUPT6H interactions | URI1 EED POLR2F BAZ1B SRPK2 STT3B GPALPP1 POLR3E SUPT6H FBXW7 | 1.00e-06 | 220 | 123 | 10 | int:SUPT6H |
| Interaction | NUCKS1 interactions | 1.00e-06 | 220 | 123 | 10 | int:NUCKS1 | |
| Interaction | PPP1CA interactions | KIF13B LIMA1 URI1 EED LEO1 BMP2K CNST MARCHF6 PPP1R26 UBR5 POLR3E SUPT6H GLI3 PPP1R1B SPRED1 HERC2 PARD3 | 1.14e-06 | 696 | 123 | 17 | int:PPP1CA |
| Interaction | H2BC21 interactions | RIOK1 EED LEO1 KAT6A BAZ1B CHD7 CHRAC1 RFC1 SRCAP PAF1 PTMA PBRM1 SUPT6H PHF14 USP15 ZNF292 FBXW7 | 1.14e-06 | 696 | 123 | 17 | int:H2BC21 |
| Interaction | SNRNP40 interactions | PMS1 SFSWAP KAT6A BMS1 SRPK2 ZFC3H1 RFC1 PAF1 GPALPP1 UBR5 CEBPZ SUPT6H SENP6 ZNF830 USP48 USP15 | 1.69e-06 | 637 | 123 | 16 | int:SNRNP40 |
| Interaction | RPS19 interactions | CCDC8 RIOK1 HNRNPCL1 KAT6A BMS1 BAZ1B SRPK2 STT3B HNRNPCL3 MFAP1 CEBPZ HERC2 USP48 USP15 HNRNPCL2 FBXW7 | 1.76e-06 | 639 | 123 | 16 | int:RPS19 |
| Interaction | MYCBP2 interactions | SLAIN2 CCDC8 LIMA1 EED SRPK2 DST MDN1 LSM14A HERC2 USP15 HNRNPCL2 FBXW7 | 1.85e-06 | 355 | 123 | 12 | int:MYCBP2 |
| Interaction | KAT8 interactions | 1.88e-06 | 95 | 123 | 7 | int:KAT8 | |
| Interaction | RNPS1 interactions | EED SFSWAP BMP2K RBM33 KAT6A SRPK2 ZBTB14 GPALPP1 ZC3H11A UBR5 SUPT6H PHF14 HERC2 | 2.04e-06 | 425 | 123 | 13 | int:RNPS1 |
| Interaction | SENP3 interactions | DCAF1 EED KAT6A RFC1 PAF1 PBRM1 MDN1 HECW2 ATF7IP USP15 HNRNPCL2 | 2.40e-06 | 301 | 123 | 11 | int:SENP3 |
| Interaction | SMC5 interactions | PMS1 EED HNRNPCL1 SFSWAP RBM33 BAZ1B CHD7 RFC1 PAF1 HNRNPCL3 MFAP1 ZC3H11A SAFB CEBPZ ATF7IP SENP6 PHF14 ZNF830 STAG2 HNRNPCL2 | 2.65e-06 | 1000 | 123 | 20 | int:SMC5 |
| Interaction | RPL7A interactions | DCAF1 CCDC8 RIOK1 EED KAT6A BMS1 SRPK2 CHD7 C9orf43 CEBPZ CCDC47 DNAJC1 HERC2 USP48 USP15 FBXW7 | 3.84e-06 | 679 | 123 | 16 | int:RPL7A |
| Interaction | GPN3 interactions | 4.18e-06 | 107 | 123 | 7 | int:GPN3 | |
| Interaction | SOX2 interactions | DCAF1 SLAIN2 LIMA1 EED LEO1 BAZ1B SRPK2 CHD7 RFC1 PAF1 STT3B MSN MFAP1 THBS1 PBRM1 MDN1 UBR5 GLI3 SMARCA2 LSM14A USP15 STAG2 RHOT1 ZNF292 | 4.52e-06 | 1422 | 123 | 24 | int:SOX2 |
| Interaction | HMGN5 interactions | 4.75e-06 | 154 | 123 | 8 | int:HMGN5 | |
| Interaction | POLR2A interactions | CCDC8 URI1 EED LEO1 POLR2F BAZ1B SRPK2 PAF1 SAFB POLR3E SUPT6H ATF7IP SMARCA2 FBXW7 | 5.07e-06 | 536 | 123 | 14 | int:POLR2A |
| Interaction | BAZ1A interactions | 5.22e-06 | 156 | 123 | 8 | int:BAZ1A | |
| Interaction | MSH6 interactions | 6.47e-06 | 271 | 123 | 10 | int:MSH6 | |
| Interaction | POLD1 interactions | 7.07e-06 | 337 | 123 | 11 | int:POLD1 | |
| Interaction | NAA40 interactions | PMS1 LIMA1 RIOK1 EED BAZ1B RFC1 SRCAP PAF1 CHMP2B PTMA GPALPP1 ZC3H11A SAFB DST ATF7IP SENP6 LSM14A EIF3C HNRNPCL2 | 7.35e-06 | 978 | 123 | 19 | int:NAA40 |
| Interaction | SNRPA interactions | RIOK1 EED LEO1 SRPK2 ZFC3H1 PAF1 MFAP1 ZC3H11A SAFB POLR3E SUPT6H ZNF830 USP48 | 8.01e-06 | 482 | 123 | 13 | int:SNRPA |
| Interaction | POLR1A interactions | 8.38e-06 | 220 | 123 | 9 | int:POLR1A | |
| Interaction | RPL28 interactions | FAT4 CCDC8 RIOK1 EED POLE KAT6A BMS1 SRPK2 CEBPZ ZNF830 DNAJC1 USP15 FBXW7 | 1.04e-05 | 494 | 123 | 13 | int:RPL28 |
| Interaction | H3C3 interactions | PMS1 RIOK1 EED BAZ1B CHD7 RFC1 SRCAP PBRM1 SUPT6H PHF14 USP48 STAG2 ZNF292 | 1.06e-05 | 495 | 123 | 13 | int:H3C3 |
| Interaction | H1-4 interactions | CCDC8 LIMA1 RIOK1 EED LEO1 BMS1 BAZ1B SRPK2 ZFC3H1 RFC1 MFAP1 ZC3H11A CEBPZ USP48 FBXW7 | 1.13e-05 | 656 | 123 | 15 | int:H1-4 |
| Interaction | TEX10 interactions | 1.21e-05 | 175 | 123 | 8 | int:TEX10 | |
| Interaction | DHX8 interactions | SFSWAP SRPK2 ZFC3H1 PAF1 GPALPP1 MFAP1 ZC3H11A SAFB ZNF830 USP48 | 1.24e-05 | 292 | 123 | 10 | int:DHX8 |
| Interaction | MEN1 interactions | KIF13B EED BMS1 BAZ1B SRPK2 ZFC3H1 RFC1 SRCAP PAF1 TUBB6 MFAP1 ZC3H11A SAFB PBRM1 MDN1 UBR5 CEBPZ EIF3C RERE | 1.50e-05 | 1029 | 123 | 19 | int:MEN1 |
| Interaction | TCEA1 interactions | 1.59e-05 | 131 | 123 | 7 | int:TCEA1 | |
| Interaction | U2AF1 interactions | 1.63e-05 | 239 | 123 | 9 | int:U2AF1 | |
| Interaction | RPL31 interactions | RIOK1 EED LEO1 KAT6A BMS1 SRPK2 RFC1 PAF1 STT3B MFAP1 CEBPZ CCDC47 SUPT6H USP15 FBXW7 | 1.72e-05 | 680 | 123 | 15 | int:RPL31 |
| Interaction | SIRT6 interactions | FAT4 CCDC8 SRPK2 ZFC3H1 SRCAP TUBB6 PBRM1 UBR5 CEBPZ SUPT6H SMARCA2 HERC2 USP48 USP15 | 2.98e-05 | 628 | 123 | 14 | int:SIRT6 |
| Interaction | IFI16 interactions | RIOK1 IPO8 BMS1 BAZ1B RFC1 PAF1 HNRNPCL3 SAFB PBRM1 CEBPZ OSBPL8 PHF14 EIF3C USP15 FBXW7 | 3.03e-05 | 714 | 123 | 15 | int:IFI16 |
| Interaction | ACTB interactions | DR1 LIMA1 RIOK1 EED LEO1 BAZ1B SRPK2 SRCAP CHMP2B PTMA MSN PBRM1 DST ATF7IP SMARCA2 LSM14A USP48 USP15 STAG2 | 3.05e-05 | 1083 | 123 | 19 | int:ACTB |
| Interaction | SRPK2 interactions | SLAIN2 EED AMER1 HNRNPCL1 SFSWAP RASGRF1 KAT6A BMS1 SRPK2 ZFC3H1 MFAP1 SAFB CEBPZ SUPT6H FBXW7 | 3.18e-05 | 717 | 123 | 15 | int:SRPK2 |
| Interaction | TBK1 interactions | BORCS6 CCDC8 EED CNTRL PTMA MFAP1 DST POLR3E HERC2 USP15 FBXW7 | 3.62e-05 | 402 | 123 | 11 | int:TBK1 |
| Interaction | ZBBX interactions | 3.66e-05 | 31 | 123 | 4 | int:ZBBX | |
| Interaction | DDX23 interactions | LEO1 SFSWAP BMS1 SRPK2 PAF1 GPALPP1 MFAP1 SAFB UBR5 CEBPZ SUPT6H FBXW7 | 3.82e-05 | 480 | 123 | 12 | int:DDX23 |
| Interaction | PRPF6 interactions | CCDC8 RIOK1 EED KAT6A SRPK2 SMARCA2 EIF3C STAG2 HNRNPCL2 FBXW7 | 4.12e-05 | 336 | 123 | 10 | int:PRPF6 |
| Interaction | RNF4 interactions | DCAF1 LIMA1 HNRNPCL1 IPO8 BMP2K RBM33 BAZ1B SRPK2 ZFC3H1 BIRC6 STRIP1 STT3B SAFB PBRM1 CEBPZ ATF7IP GLI3 OSBPL8 GOLIM4 DNAJC1 RERE HNRNPCL2 | 4.12e-05 | 1412 | 123 | 22 | int:RNF4 |
| Interaction | SUPT5H interactions | RIOK1 EED LEO1 NELFCD RBM33 POLR2F BAZ1B CHD7 PAF1 UBR5 SUPT6H | 4.14e-05 | 408 | 123 | 11 | int:SUPT5H |
| Interaction | POLR2C interactions | URI1 LEO1 NELFCD CNTRL POLR2F BAZ1B BIRC6 POLR3E SUPT6H ATF7IP | 4.33e-05 | 338 | 123 | 10 | int:POLR2C |
| Interaction | DEK interactions | 4.34e-05 | 209 | 123 | 8 | int:DEK | |
| Interaction | POLR2K interactions | 4.68e-05 | 155 | 123 | 7 | int:POLR2K | |
| Interaction | POLE3 interactions | 4.74e-05 | 106 | 123 | 6 | int:POLE3 | |
| Interaction | SLX4 interactions | PMS1 IPO8 RBM33 ZFC3H1 PAF1 TUBB6 MFAP1 SAFB MDN1 UBR5 SUPT6H ATF7IP SENP6 | 4.80e-05 | 572 | 123 | 13 | int:SLX4 |
| Interaction | RPAP2 interactions | 5.50e-05 | 159 | 123 | 7 | int:RPAP2 | |
| Interaction | PPP2R1A interactions | DCAF1 PMS1 CCDC8 URI1 RIOK1 EED LEO1 CNTRL VTA1 STRIP1 MSN USP48 USP15 FBXW7 | 5.55e-05 | 665 | 123 | 14 | int:PPP2R1A |
| Interaction | SUPT4H1 interactions | 5.57e-05 | 67 | 123 | 5 | int:SUPT4H1 | |
| Interaction | MYH9 interactions | DCAF1 KIF13B LIMA1 RIOK1 EED BMP2K VTA1 PTMA MSN THBS1 DST EIF3C USP48 USP15 FBXW7 | 5.64e-05 | 754 | 123 | 15 | int:MYH9 |
| Interaction | SEM1 interactions | 6.20e-05 | 162 | 123 | 7 | int:SEM1 | |
| Interaction | IQGAP1 interactions | CCDC8 LIMA1 CLUAP1 RIOK1 EED BMP2K CLIP1 DST POLR3E GOLIM4 LSM14A USP15 STAG2 | 6.69e-05 | 591 | 123 | 13 | int:IQGAP1 |
| Interaction | NIFK interactions | 6.78e-05 | 431 | 123 | 11 | int:NIFK | |
| Interaction | KAT6A interactions | DCAF1 SLAIN2 KAT6A SRPK2 STT3B ZBTB39 PBRM1 CEBPZ CCDC47 PHF14 RERE USP15 | 6.84e-05 | 510 | 123 | 12 | int:KAT6A |
| Interaction | EIF4G1 interactions | CCDC8 EED IPO8 NELFCD POLE SRPK2 MSN MFAP1 EIF3C HERC2 FBXW7 | 7.07e-05 | 433 | 123 | 11 | int:EIF4G1 |
| Interaction | ACTL6A interactions | 7.15e-05 | 289 | 123 | 9 | int:ACTL6A | |
| Interaction | HDAC2 interactions | DCAF1 SLAIN2 CCDC8 LIMA1 EED BMP2K PTMA MSN SMARCA2 PHF14 LSM14A RERE HERC2 USP15 STAG2 FBXW7 | 7.43e-05 | 865 | 123 | 16 | int:HDAC2 |
| Interaction | CHMP2A interactions | 8.23e-05 | 117 | 123 | 6 | int:CHMP2A | |
| Interaction | PSMD1 interactions | CCDC8 LIMA1 EED LEO1 SFSWAP VTA1 MFAP1 EIF3C HERC2 USP15 STAG2 | 8.49e-05 | 442 | 123 | 11 | int:PSMD1 |
| Interaction | SUPT16H interactions | RIOK1 EED LEO1 BAZ1B SRPK2 PAF1 UBR5 SUPT6H SMARCA2 PHF14 FBXW7 | 8.49e-05 | 442 | 123 | 11 | int:SUPT16H |
| Interaction | RPL23A interactions | DCAF1 RIOK1 EED IPO8 KAT6A BMS1 SRPK2 ZFC3H1 CLIP1 SAFB DST USP15 FBXW7 | 8.60e-05 | 606 | 123 | 13 | int:RPL23A |
| Interaction | MED14 interactions | 8.71e-05 | 171 | 123 | 7 | int:MED14 | |
| Interaction | GAR1 interactions | 9.04e-05 | 232 | 123 | 8 | int:GAR1 | |
| Interaction | CPSF6 interactions | CCDC8 EED LEO1 P3H3 SRPK2 ZFC3H1 PAF1 MFAP1 ZC3H11A SAFB SUPT6H ZNF830 | 9.17e-05 | 526 | 123 | 12 | int:CPSF6 |
| Interaction | TULP2 interactions | 9.21e-05 | 39 | 123 | 4 | int:TULP2 | |
| Interaction | H2AZ1 interactions | 9.40e-05 | 371 | 123 | 10 | int:H2AZ1 | |
| Interaction | POLR2B interactions | 9.40e-05 | 371 | 123 | 10 | int:POLR2B | |
| Interaction | ENO1 interactions | FAT4 CCDC8 RIOK1 EED PAF1 STRIP1 PTMA MSN UBR5 USP48 USP15 TRIM44 STAG2 FBXW7 | 9.72e-05 | 701 | 123 | 14 | int:ENO1 |
| Interaction | MED4 interactions | RIOK1 TTLL5 CNTRL POLR2F DST UBR5 POLR3E ATF7IP HERC2 USP15 FBXW7 | 9.95e-05 | 450 | 123 | 11 | int:MED4 |
| Interaction | NAT10 interactions | 1.00e-04 | 302 | 123 | 9 | int:NAT10 | |
| Interaction | PNN interactions | 1.00e-04 | 302 | 123 | 9 | int:PNN | |
| Interaction | RUVBL2 interactions | CCDC8 DR1 URI1 RIOK1 EED LEO1 SRCAP UBR5 POLR3E SUPT6H SENP6 USP15 FBXW7 | 1.01e-04 | 616 | 123 | 13 | int:RUVBL2 |
| Interaction | NCL interactions | DCAF1 CCDC8 RIOK1 EED SRPK2 RFC1 PTMA SUPT6H EIF3C DNAJC1 HERC2 USP48 STAG2 FBXW7 BRWD1 | 1.06e-04 | 798 | 123 | 15 | int:NCL |
| Interaction | RPL8 interactions | CCDC8 RIOK1 EED KAT6A BMS1 CHD7 UBR5 CEBPZ ATF7IP EIF3C DNAJC1 FBXW7 | 1.15e-04 | 539 | 123 | 12 | int:RPL8 |
| Interaction | POLR2G interactions | 1.16e-04 | 179 | 123 | 7 | int:POLR2G | |
| Interaction | DOT1L interactions | LIMA1 SFSWAP BMS1 BAZ1B SRPK2 ZFC3H1 RFC1 TUBB6 ZC3H11A SAFB PBRM1 MDN1 CEBPZ LSM14A EIF3C | 1.20e-04 | 807 | 123 | 15 | int:DOT1L |
| Cytoband | 12q24.3 | 1.06e-04 | 6 | 123 | 2 | 12q24.3 | |
| Cytoband | 12q14 | 3.85e-04 | 11 | 123 | 2 | 12q14 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.97e-06 | 181 | 84 | 8 | 694 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Paf1/RNA polymerase II complex | 3.16e-04 | 6 | 84 | 2 | 1029 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.92e-03 | 53 | 84 | 3 | 532 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SECISBP2L PMS1 URI1 BMP2K KAT6A MARCHF6 BAZ1B SRPK2 CLIP1 PIKFYVE THBS2 DST MDN1 UBR5 NMT2 SMARCA2 OSBPL8 PHF14 WDFY3 PARD3 USP15 TRIM44 STAG2 ZNF292 | 1.29e-12 | 856 | 122 | 24 | M4500 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SLAIN2 DR1 URI1 RBM33 CNTRL KAT6A MARCHF6 ANKRD49 BAZ1B ZFC3H1 APOBR BIRC6 CLIP1 STT3B PTMA MSN PIKFYVE ZC3H11A UBR5 ATF7IP SMARCA2 OSBPL8 SENP6 LSM14A USP15 STAG2 ZNF292 BRWD1 | 1.80e-10 | 1492 | 122 | 28 | M40023 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | LIMA1 BAZ1B SLC24A3 RFC1 CLIP1 CHMP2B GPALPP1 MFAP1 PBRM1 CEBPZ CCDC47 ATF7IP KCNJ5 SMARCA2 OSBPL8 GOLIM4 DNAJC1 USP48 STAG2 | 2.13e-10 | 656 | 122 | 19 | M18979 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | PMS1 KAT6A MARCHF6 SRPK2 CLIP1 PIKFYVE THBS2 DST MDN1 UBR5 NMT2 SMARCA2 OSBPL8 PARD3 ZNF292 | 4.85e-09 | 466 | 122 | 15 | M13522 |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | SECISBP2L SLAIN2 RIOK1 SFSWAP CNST RBM33 KAT6A MARCHF6 CHD7 ZFC3H1 RFC1 STT3B THBS1 POLR3E CEBPZ ZNF292 BRWD1 | 1.83e-08 | 680 | 122 | 17 | M41089 |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_DN | 4.25e-07 | 200 | 122 | 9 | M8997 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | PMS1 KAT6A MARCHF6 BAZ1B ZFC3H1 PIKFYVE DST UBR5 LSM14A WDFY3 | 1.48e-06 | 300 | 122 | 10 | M8702 |
| Coexpression | GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_6H_UP | 4.57e-06 | 200 | 122 | 8 | M6415 | |
| Coexpression | GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_UP | 4.57e-06 | 200 | 122 | 8 | M4884 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN | 2.62e-05 | 37 | 122 | 4 | MM570 | |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | EED ZFC3H1 SCAPER SMARCA2 OSBPL8 SENP6 LSM14A WDFY3 HERC2 RHOT1 | 3.35e-05 | 429 | 122 | 10 | M29 |
| Coexpression | GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN | 3.69e-05 | 195 | 122 | 7 | M5330 | |
| Coexpression | GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_DN | 4.33e-05 | 200 | 122 | 7 | M5529 | |
| Coexpression | GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_UP | 4.33e-05 | 200 | 122 | 7 | M9258 | |
| Coexpression | GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_TREATED_CD4_TCELL_UP | 4.33e-05 | 200 | 122 | 7 | M5623 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | SECISBP2L DR1 URI1 SFSWAP BMP2K CNTRL MARCHF6 ANKRD49 SRPK2 CLIP1 MDN1 UBR5 CCDC47 OSBPL8 SENP6 USP15 RHOT1 | 4.86e-05 | 1215 | 122 | 17 | M41122 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | 5.24e-05 | 363 | 122 | 9 | M41103 | |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 6.17e-05 | 145 | 122 | 6 | M1810 | |
| Coexpression | ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP | PMS1 DR1 URI1 EED VTA1 STT3B CHMP2B CEBPZ SENP6 PHF14 LSM14A FBXW7 | 8.96e-05 | 687 | 122 | 12 | M41022 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | FAT4 LIMA1 HNRNPCL1 ZBTB14 HNRNPCL3 PIKFYVE SMARCA2 GOLIM4 DNAJC1 HNRNPCL2 | 9.16e-05 | 484 | 122 | 10 | MM999 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | RBM33 ANKRD49 BAZ1B SRPK2 NCKAP5 CHD7 NLGN1 CLIP1 MFAP1 SAFB UBR5 CEBPZ GLI3 GOLIM4 PHF14 DNAJC1 RERE USP48 USP15 ZNF292 FBXW7 | 1.06e-08 | 831 | 122 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | PMS1 URI1 KAT6A ANKRD49 BAZ1B NCKAP5 CHD7 SRCAP PAF1 CLIP1 MFAP1 SUPT6H SENP6 LSM14A WDFY3 STAG2 ZNF292 | 5.41e-08 | 595 | 122 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | FAT4 EED LEO1 SLC24A3 NCKAP5 CHD7 NLGN1 BMP6 THBS2 SAFB DST UBR5 CEBPZ GLI3 PHF14 DNAJC1 FBXW7 | 2.08e-07 | 654 | 122 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | URI1 KAT6A ANKRD49 BAZ1B CHD7 NLGN1 CLIP1 BMP6 THBS2 ZC3H11A SUPT6H GLI3 LSM14A WDFY3 ZNF292 | 3.31e-06 | 629 | 122 | 15 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.27e-05 | 311 | 122 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | IPO8 SFSWAP BAZ1B BIRC6 CLIP1 THBS1 GLI3 SCAPER DNAJC1 HERC2 TRIM44 | 1.40e-05 | 385 | 122 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | URI1 RIOK1 KAT6A BAZ1B CHD7 CLIP1 ZC3H11A SUPT6H SPRED1 LSM14A WDFY3 ZNF292 BRWD1 | 2.23e-05 | 564 | 122 | 13 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.31e-05 | 203 | 122 | 8 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | DCAF1 PMS1 URI1 EED IPO8 LEO1 POLE CNTRL ANKRD49 BAZ1B CHD7 RFC1 CLIP1 MDN1 GLI3 KCNJ5 SPRED1 PHF14 DNAJC1 ZNF292 FBXW7 BRWD1 | 2.70e-05 | 1459 | 122 | 22 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | DCAF1 PMS1 URI1 EED IPO8 LEO1 POLE CNTRL ANKRD49 BAZ1B RFC1 CLIP1 MDN1 GLI3 SPRED1 PHF14 DNAJC1 ZNF292 FBXW7 BRWD1 | 3.12e-05 | 1257 | 122 | 20 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | SLAIN2 RBM33 TTLL5 BAZ1B SRPK2 CHD7 CLIP1 PIKFYVE MFAP1 BMP6 GOLIM4 PHF14 RERE USP48 FBXW7 | 4.17e-05 | 780 | 122 | 15 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | ANKRD49 BAZ1B NCKAP5 CHD7 NLGN1 IRX1 CLIP1 SAFB UBR5 CEBPZ GLI3 PHF14 DNAJC1 USP15 ZNF292 FBXW7 BRWD1 | 5.09e-05 | 989 | 122 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.60e-05 | 230 | 122 | 8 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | POLE BAZ1B CHD7 DST CEBPZ GLI3 LSM14A EIF3C PARD3 USP15 ZNF292 | 8.42e-05 | 469 | 122 | 11 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 9.80e-05 | 185 | 122 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.19e-04 | 328 | 122 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 1.24e-04 | 192 | 122 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.28e-04 | 259 | 122 | 8 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | DR1 SFSWAP SRPK2 RFC1 BIRC6 BMP6 THBS1 ZC3H11A NMT2 SCAPER SPRED1 DNAJC1 WDFY3 PARD3 | 1.38e-04 | 770 | 122 | 14 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | DR1 SFSWAP RFC1 SRCAP BIRC6 THBS1 THBS2 ZC3H11A NMT2 DDX25 SCAPER SPRED1 DNAJC1 WDFY3 | 1.54e-04 | 778 | 122 | 14 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.89e-04 | 349 | 122 | 9 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.99e-04 | 432 | 122 | 10 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.02e-04 | 277 | 122 | 8 | gudmap_developingGonad_e12.5_ovary_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.15e-04 | 210 | 122 | 7 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | FAT4 BAZ1B SRPK2 RFC1 BIRC6 CLIP1 TUBB6 THBS1 THBS2 AK5 GLI3 ZNF830 HERC2 TRIM44 | 2.36e-04 | 811 | 122 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.40e-04 | 151 | 122 | 6 | gudmap_developingGonad_P2_ovary_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 2.52e-04 | 532 | 122 | 11 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.85e-04 | 397 | 122 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.64e-04 | 323 | 122 | 8 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.98e-04 | 249 | 122 | 7 | gudmap_developingGonad_P2_epididymis_1000_k3 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | 6.88e-04 | 333 | 122 | 8 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | AMER1 SFSWAP SLC24A3 SRCAP BIRC6 BMP6 THBS2 ZC3H11A NMT2 SMARCA2 SPRED1 DNAJC1 WDFY3 | 6.92e-04 | 799 | 122 | 13 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 7.54e-04 | 259 | 122 | 7 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | DR1 AMER1 SFSWAP SRPK2 CHD7 SRCAP BIRC6 MSN ZC3H11A PBRM1 NMT2 DNAJC1 WDFY3 | 8.31e-04 | 815 | 122 | 13 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | FAT4 IPO8 SFSWAP BAZ1B BIRC6 CLIP1 THBS1 ZBTB39 GLI3 SCAPER DNAJC1 HERC2 TRIM44 | 8.59e-04 | 818 | 122 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | SLAIN2 LIMA1 RFC1 CLIP1 ZC3H11A DST SMARCA2 OSBPL8 STAG2 ZNF292 BRWD1 | 9.61e-12 | 199 | 123 | 11 | c425e7975f492ed5cfcca022248adb627e1d27d4 |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-09 | 191 | 123 | 9 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | SLAIN2 CNTRL SRPK2 CLIP1 ZC3H11A SMARCA2 OSBPL8 STAG2 ZNF292 | 4.60e-09 | 199 | 123 | 9 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-08 | 184 | 123 | 8 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.18e-08 | 191 | 123 | 8 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.18e-08 | 191 | 123 | 8 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 8.48e-08 | 199 | 123 | 8 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.74e-07 | 186 | 123 | 7 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.74e-07 | 186 | 123 | 7 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | ASK452-Immune-Mast_cell|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.39e-07 | 188 | 123 | 7 | 840215e16cff90f821f776186284eafcf2350690 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 1.37e-06 | 199 | 123 | 7 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-06 | 199 | 123 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.42e-06 | 200 | 123 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.42e-06 | 200 | 123 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-05 | 192 | 123 | 6 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.62e-05 | 193 | 123 | 6 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 1.62e-05 | 193 | 123 | 6 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.66e-05 | 194 | 123 | 6 | 8985095f291c1b54e45f4edece49aa26e8c8b732 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.66e-05 | 194 | 123 | 6 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.81e-05 | 197 | 123 | 6 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.81e-05 | 197 | 123 | 6 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.87e-05 | 198 | 123 | 6 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.87e-05 | 198 | 123 | 6 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 1.92e-05 | 199 | 123 | 6 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 1.92e-05 | 199 | 123 | 6 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.67e-05 | 135 | 123 | 5 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 8.48e-05 | 161 | 123 | 5 | 347edb0de10850b7d16c40945751033289289c9b | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.79e-05 | 166 | 123 | 5 | 49103b75c3e08656c5774f56fd00d7bd53eefcfb | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-5_VIP_KCNJ2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.22e-04 | 174 | 123 | 5 | fdadac1eaab2c4a67e4832f0901df22e893add6a | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 1.32e-04 | 177 | 123 | 5 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.32e-04 | 177 | 123 | 5 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 1.39e-04 | 179 | 123 | 5 | 9d51318ac198a8801bd5c7031ebf2b0c74ffeeb6 | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_4|COVID-19_Convalescent / Disease condition and Cell class | 1.39e-04 | 179 | 123 | 5 | 366e4a31db9e80fd1770ac9f1ae148fefeb9f7df | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.39e-04 | 179 | 123 | 5 | 40441de2d679733ecbf2145fabc3ed65a53310eb | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-04 | 182 | 123 | 5 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 182 | 123 | 5 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.63e-04 | 185 | 123 | 5 | 16e9ccea0e3b95d90dc48ef74206c805681dac0b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.63e-04 | 185 | 123 | 5 | 027020754dbf71b0034791f9a34ae795e3b85f81 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.63e-04 | 185 | 123 | 5 | 2e1766f1a972fecd670daaaf7eb2d3a404f121e7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.63e-04 | 185 | 123 | 5 | 7aaa8335b40927e3e8fdcede807cd521fc213a0d | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 185 | 123 | 5 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.63e-04 | 185 | 123 | 5 | 0b5a0df58ae2ad8261f40f152775747af4f3937a | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.67e-04 | 186 | 123 | 5 | e044b3428b7eacfdc72d0f57cdabaa1de04c74cd | |
| ToppCell | normal_Lung-MAST_cells|normal_Lung / Location, Cell class and cell subclass | 1.80e-04 | 189 | 123 | 5 | f09e387dc0626536050cd537dda212471a7267c4 | |
| ToppCell | normal_Lung-MAST_cells-MAST|normal_Lung / Location, Cell class and cell subclass | 1.80e-04 | 189 | 123 | 5 | fd053209034fca6eaefe0e5ad024ac4548a100c9 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.84e-04 | 190 | 123 | 5 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.84e-04 | 190 | 123 | 5 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.84e-04 | 190 | 123 | 5 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.84e-04 | 190 | 123 | 5 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | COPD-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 1.88e-04 | 191 | 123 | 5 | 3ae18bc4e3dff49b5d5958da8ebc3f747274b69c | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.88e-04 | 191 | 123 | 5 | a53616c84178eb6c29b48662358765b082df3f97 | |
| ToppCell | ASK452-Immune-Mast_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.93e-04 | 192 | 123 | 5 | 8269b88ff6073a908f547fcc7c5941f2e8289694 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.93e-04 | 192 | 123 | 5 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | cellseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.93e-04 | 192 | 123 | 5 | b29d6b4bed4d55060586276973732461538752df | |
| ToppCell | ASK454-Immune-Mast_cell|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.93e-04 | 192 | 123 | 5 | 4ab2524cce70b6a3a3dd31085b421565a7406c56 | |
| ToppCell | ASK454-Immune-Mast_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.93e-04 | 192 | 123 | 5 | 01e6324146ea34785b770231b40f7a18f128f526 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.93e-04 | 192 | 123 | 5 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.98e-04 | 193 | 123 | 5 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.98e-04 | 193 | 123 | 5 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.98e-04 | 193 | 123 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.98e-04 | 193 | 123 | 5 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.98e-04 | 193 | 123 | 5 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.98e-04 | 193 | 123 | 5 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.98e-04 | 193 | 123 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.98e-04 | 193 | 123 | 5 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 2.03e-04 | 194 | 123 | 5 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.03e-04 | 194 | 123 | 5 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.07e-04 | 195 | 123 | 5 | a4d36654b968acb1aea252ac203683939461f1d1 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.07e-04 | 195 | 123 | 5 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-04 | 195 | 123 | 5 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.07e-04 | 195 | 123 | 5 | cd811abd949ef201aef1c8515da5575ab1b1cfea | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 2.12e-04 | 196 | 123 | 5 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.12e-04 | 196 | 123 | 5 | 525d6c8a277364e624e7cc586275f8a891436b57 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.12e-04 | 196 | 123 | 5 | 0175b097ad1338a07afebe3b5c7fd0bb0bb950f7 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer-37|World / Primary Cells by Cluster | 2.18e-04 | 197 | 123 | 5 | 00d756bc0231e1b3b88430214338c1059cb11106 | |
| ToppCell | P03-Mesenchymal-myocytic_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.18e-04 | 197 | 123 | 5 | 079db904a08743b3c555cb7b3f5fb5c978dde25a | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 2.18e-04 | 197 | 123 | 5 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 2.18e-04 | 197 | 123 | 5 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.18e-04 | 197 | 123 | 5 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 2.23e-04 | 198 | 123 | 5 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.23e-04 | 198 | 123 | 5 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.23e-04 | 198 | 123 | 5 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.23e-04 | 198 | 123 | 5 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-04 | 198 | 123 | 5 | 22559b161e67b49fe8028bfaf861e069063599f5 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG-20|World / Primary Cells by Cluster | 2.23e-04 | 198 | 123 | 5 | bce0bc1e3f2257e0f42a1fa6e5b57cf71e4514ba | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.28e-04 | 199 | 123 | 5 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.28e-04 | 199 | 123 | 5 | ce699726ac4825c65bf934cb9a76202ad7340596 | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-dn_T|Leuk-UTI / Disease, condition lineage and cell class | 2.28e-04 | 199 | 123 | 5 | aa4d8ce8994e5032a33d5cc68c482882147cdc3b | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 2.28e-04 | 199 | 123 | 5 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type. | 2.28e-04 | 199 | 123 | 5 | b2d7dea11207cca63d688f8051143850b29dbdf0 | |
| ToppCell | Fibroblasts-CD34+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.28e-04 | 199 | 123 | 5 | 13ff7409e200a0b46cdb7924d15ef33639693622 | |
| ToppCell | (7)_Mast_cell|World / shred on Cell_type and subtype | 2.28e-04 | 199 | 123 | 5 | c0b5f1cb435da99a7e2ebac9ee7d7b1bd0e49b42 | |
| ToppCell | Caecum-(7)_Mast_cell|Caecum / shred on region, Cell_type, and subtype | 2.33e-04 | 200 | 123 | 5 | d23fe8644ce42ace51fcde43cb4cd22a99300c02 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CBLN1-L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.33e-04 | 200 | 123 | 5 | 2086024ce808b8796ed508a229b098eb02f8828a | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-Mast_cell-Mast_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.33e-04 | 200 | 123 | 5 | 4090f2ab8529a530043f3917472f2d9ca7c9b1df | |
| ToppCell | Transverse-(7)_Mast_cell-(70)_Mast|Transverse / shred on region, Cell_type, and subtype | 2.33e-04 | 200 | 123 | 5 | aa17354c83b0967707d995e4b74e042ac211f814 | |
| ToppCell | Sigmoid-(7)_Mast_cell-(70)_Mast|Sigmoid / shred on region, Cell_type, and subtype | 2.33e-04 | 200 | 123 | 5 | 7224ee639d56509de854203653a85ab09e6f05fe | |
| ToppCell | Transverse-Mast_cell-Mast|Transverse / Region, Cell class and subclass | 2.33e-04 | 200 | 123 | 5 | 0af942a33cc50da65129204976e24203320e206d | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-Mast_cell|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.33e-04 | 200 | 123 | 5 | cc78aa3e29f6c0a44c373dde7785c0e61978cf2d | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.33e-04 | 200 | 123 | 5 | d0167f96314be78b6d867bbcc6e4396071d931b8 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.09e-05 | 50 | 79 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Computational | Neighborhood of RAD54L | 1.17e-04 | 105 | 79 | 6 | MORF_RAD54L | |
| Computational | Neighborhood of EIF4E | 3.91e-04 | 85 | 79 | 5 | MORF_EIF4E | |
| Drug | ikarugamycin; Up 200; 2uM; MCF7; HT_HG-U133A_EA | 1.02e-06 | 195 | 121 | 9 | 866_UP | |
| Drug | clozapine; Up 200; 10uM; MCF7; HT_HG-U133A | 1.06e-06 | 196 | 121 | 9 | 1654_UP | |
| Drug | Gliclazide [21187-98-4]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 1.11e-06 | 197 | 121 | 9 | 2870_DN | |
| Drug | Clorgyline | 3.30e-06 | 168 | 121 | 8 | ctd:D003010 | |
| Drug | geldanamycin | SLAIN2 LIMA1 IPO8 KAT6A CLIP1 THBS1 ZC3H11A DST SMARCA2 OSBPL8 GOLIM4 | 4.78e-06 | 371 | 121 | 11 | ctd:C001277 |
| Drug | 3-Acetylcoumarin [3949-36-8]; Down 200; 21.2uM; MCF7; HT_HG-U133A | 8.82e-06 | 192 | 121 | 8 | 3382_DN | |
| Drug | 2-Aminobenzenesulfonamide [3306-62-5]; Down 200; 23.2uM; MCF7; HT_HG-U133A | 8.82e-06 | 192 | 121 | 8 | 3400_DN | |
| Drug | Tiapride hydrochloride [51012-33-0]; Down 200; 11uM; MCF7; HT_HG-U133A | 8.82e-06 | 192 | 121 | 8 | 2292_DN | |
| Drug | Cefaclor [70356-03-5]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 9.51e-06 | 194 | 121 | 8 | 4967_UP | |
| Drug | Prednisone [53-03-2]; Up 200; 11.2uM; PC3; HT_HG-U133A | 9.88e-06 | 195 | 121 | 8 | 4577_UP | |
| Drug | Methoxy-6-harmalan [3589-73-9]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 9.88e-06 | 195 | 121 | 8 | 5455_DN | |
| Drug | Quinic acid [86-68-0]; Down 200; 19.6uM; PC3; HT_HG-U133A | 1.03e-05 | 196 | 121 | 8 | 7317_DN | |
| Drug | Kaempferol [520-18-3]; Down 200; 14uM; MCF7; HT_HG-U133A | 1.06e-05 | 197 | 121 | 8 | 3579_DN | |
| Drug | Biotin [58-85-5]; Down 200; 16.4uM; HL60; HT_HG-U133A | 1.10e-05 | 198 | 121 | 8 | 2428_DN | |
| Drug | N-ethyl-N-nitrosourea | 1.67e-05 | 275 | 121 | 9 | CID000012967 | |
| Drug | R(-)-Denopamine | 2.76e-05 | 33 | 121 | 4 | CID000003818 | |
| Drug | 6-azauracil | 4.11e-05 | 72 | 121 | 5 | CID000068037 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 6.04e-05 | 185 | 121 | 7 | 831_UP | |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; PC3; HT_HG-U133A | 7.63e-05 | 192 | 121 | 7 | 4311_DN | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 7.89e-05 | 193 | 121 | 7 | 3262_UP | |
| Drug | Betahistine mesylate [54856-23-4]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 7.89e-05 | 193 | 121 | 7 | 2833_DN | |
| Drug | Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; PC3; HT_HG-U133A | 7.89e-05 | 193 | 121 | 7 | 4338_DN | |
| Drug | Methionine phosphonate | 7.98e-05 | 43 | 121 | 4 | CID000444719 | |
| Drug | Karakoline [39089-30-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 8.41e-05 | 195 | 121 | 7 | 6059_DN | |
| Drug | Metolazone [17560-51-9]; Up 200; 11uM; MCF7; HT_HG-U133A | 8.41e-05 | 195 | 121 | 7 | 5392_UP | |
| Drug | 6-mercaptopurine monohydrate; Down 200; 10uM; PC3; HG-U133A | 8.41e-05 | 195 | 121 | 7 | 667_DN | |
| Drug | Zimelidine dihydrochloride monohydrate [61129-30-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 8.69e-05 | 196 | 121 | 7 | 1512_DN | |
| Drug | Hesperidin [520-26-3]; Down 200; 6.6uM; HL60; HT_HG-U133A | 8.69e-05 | 196 | 121 | 7 | 1294_DN | |
| Drug | Oxybenzone [131-57-7]; Down 200; 17.6uM; PC3; HT_HG-U133A | 8.69e-05 | 196 | 121 | 7 | 6309_DN | |
| Drug | Paromomycin sulfate [1263-89-4]; Down 200; 5.6uM; MCF7; HT_HG-U133A | 8.69e-05 | 196 | 121 | 7 | 4420_DN | |
| Drug | Naphazoline hydrochloride [550-99-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 8.97e-05 | 197 | 121 | 7 | 4949_UP | |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 8.97e-05 | 197 | 121 | 7 | 2259_DN | |
| Drug | Ioversol [87771-40-2]; Down 200; 5uM; MCF7; HT_HG-U133A | 8.97e-05 | 197 | 121 | 7 | 3365_DN | |
| Drug | Tetrahydroxy-1,4-quinone monohydrate [319-89-1]; Down 200; 21uM; MCF7; HT_HG-U133A | 8.97e-05 | 197 | 121 | 7 | 3338_DN | |
| Drug | Perphenazine [58-39-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 8.97e-05 | 197 | 121 | 7 | 1540_DN | |
| Drug | Bezafibrate [41859-67-0]; Up 200; 11uM; PC3; HT_HG-U133A | 8.97e-05 | 197 | 121 | 7 | 6653_UP | |
| Drug | Tropicamide [1508-75-4]; Down 200; 14uM; MCF7; HT_HG-U133A | 8.97e-05 | 197 | 121 | 7 | 2309_DN | |
| Drug | Mephentermine hemisulfate [1212-72-2]; Down 200; 9.4uM; PC3; HT_HG-U133A | 9.26e-05 | 198 | 121 | 7 | 7384_DN | |
| Drug | Sulfanilamide [63-74-1]; Down 200; 23.2uM; MCF7; HT_HG-U133A | 9.26e-05 | 198 | 121 | 7 | 3449_DN | |
| Drug | Naproxen [22204-53-1]; Down 200; 17.4uM; HL60; HT_HG-U133A | 9.26e-05 | 198 | 121 | 7 | 1869_DN | |
| Drug | (+) -Levobunolol hydrochloride [47141-41-3]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 9.26e-05 | 198 | 121 | 7 | 4980_UP | |
| Drug | 5-aminosalicylic acid; Down 200; 100uM; MCF7; HG-U133A | 9.26e-05 | 198 | 121 | 7 | 124_DN | |
| Drug | Cyclopenthiazide [742-20-1]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 9.26e-05 | 198 | 121 | 7 | 7325_UP | |
| Drug | Meglumine [6284-40-8]; Down 200; 20.4uM; PC3; HT_HG-U133A | 9.26e-05 | 198 | 121 | 7 | 6685_DN | |
| Drug | Trolox [53188-07-1]; Down 200; 16uM; MCF7; HT_HG-U133A | 9.55e-05 | 199 | 121 | 7 | 2883_DN | |
| Drug | Gibberellic acid [77-06-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 9.55e-05 | 199 | 121 | 7 | 7330_DN | |
| Drug | Midodrine hydrochloride [3092-17-9]; Up 200; 13.8uM; HL60; HG-U133A | 9.55e-05 | 199 | 121 | 7 | 1403_UP | |
| Drug | Pipemidic acid [51940-44-4]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 9.55e-05 | 199 | 121 | 7 | 6470_DN | |
| Drug | Lisuride (S)(-) [18016-80-3]; Down 200; 11.8uM; HL60; HG-U133A | 9.55e-05 | 199 | 121 | 7 | 2046_DN | |
| Drug | (cis-) Nanophine [5072-45-7]; Down 200; 26.8uM; PC3; HT_HG-U133A | 9.55e-05 | 199 | 121 | 7 | 4543_DN | |
| Drug | Scopolamine hydrochloride [55-16-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 9.55e-05 | 199 | 121 | 7 | 4803_DN | |
| Drug | Carbachol [51-83-2]; Down 200; 21.8uM; MCF7; HT_HG-U133A | 9.85e-05 | 200 | 121 | 7 | 3380_DN | |
| Drug | Levocabastine hydrochloride [79547-78-7]; Down 200; 8.8uM; HL60; HT_HG-U133A | 9.85e-05 | 200 | 121 | 7 | 2948_DN | |
| Drug | SAlute | 1.67e-04 | 4 | 121 | 2 | CID000171036 | |
| Disease | Adenocarcinoma of large intestine | 4.12e-05 | 96 | 117 | 5 | C1319315 | |
| Disease | Malignant neoplasm of endometrium | 4.75e-05 | 18 | 117 | 3 | C0007103 | |
| Disease | Carcinoma in situ of endometrium | 4.75e-05 | 18 | 117 | 3 | C0346191 | |
| Disease | Adenoid Cystic Carcinoma | 5.01e-05 | 100 | 117 | 5 | C0010606 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 1.80e-04 | 131 | 117 | 5 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 1.80e-04 | 131 | 117 | 5 | C4552091 | |
| Disease | Juvenile arthritis | 1.80e-04 | 131 | 117 | 5 | C3495559 | |
| Disease | Juvenile psoriatic arthritis | 1.80e-04 | 131 | 117 | 5 | C3714758 | |
| Disease | Juvenile-Onset Still Disease | 2.07e-04 | 135 | 117 | 5 | C0087031 | |
| Disease | Sick Sinus Syndrome | 2.31e-04 | 6 | 117 | 2 | C0037052 | |
| Disease | osteoarthritis, spine, body mass index | 4.30e-04 | 8 | 117 | 2 | EFO_0004340, EFO_1000787 | |
| Disease | corticobasal degeneration disorder | 5.51e-04 | 9 | 117 | 2 | MONDO_0022308 | |
| Disease | Anorectal Malformations | 5.80e-04 | 41 | 117 | 3 | C3495676 | |
| Disease | smoking status measurement | EED POLR2F SLC24A3 CHD7 NLGN1 BIRC6 TNNI3K HECW2 PPP1R1B DNAJC1 RERE USP15 BRWD1 | 7.05e-04 | 1160 | 117 | 13 | EFO_0006527 |
| Disease | meningitis | 8.38e-04 | 11 | 117 | 2 | MONDO_0021108 | |
| Disease | Congenital long QT syndrome | 8.38e-04 | 11 | 117 | 2 | cv:C1141890 | |
| Disease | Long QT syndrome | 1.00e-03 | 12 | 117 | 2 | cv:C0023976 | |
| Disease | neuroimaging measurement | SECISBP2L POLR2F VTA1 NCKAP5 CHD7 BMP6 THBS1 GLI3 PPP1R1B SMARCA2 RERE PARD3 | 1.12e-03 | 1069 | 117 | 12 | EFO_0004346 |
| Disease | pain | 1.13e-03 | 196 | 117 | 5 | EFO_0003843 | |
| Disease | alcohol consumption measurement | SECISBP2L ZC3H11B NCKAP5 RFC1 BIRC6 STT3B MFAP1 AK5 GLI3 SCAPER SENP6 RERE PARD3 | 1.31e-03 | 1242 | 117 | 13 | EFO_0007878 |
| Disease | psychosis | 1.38e-03 | 14 | 117 | 2 | EFO_0005407 | |
| Disease | puberty onset measurement | 1.57e-03 | 125 | 117 | 4 | EFO_0005677 | |
| Disease | testosterone measurement | LIMA1 AMER1 BAZ1B ZC3H11B SLC24A3 CHD7 IRX1 SRCAP BIRC6 BMP6 SMARCA2 USP48 BRWD1 | 1.66e-03 | 1275 | 117 | 13 | EFO_0004908 |
| Disease | migraine disorder, type 2 diabetes mellitus | 1.76e-03 | 60 | 117 | 3 | MONDO_0005148, MONDO_0005277 | |
| Disease | Diabetic Angiopathies | 1.80e-03 | 16 | 117 | 2 | C0011875 | |
| Disease | Romano-Ward Syndrome | 1.80e-03 | 16 | 117 | 2 | C0035828 | |
| Disease | pancreatic ductal carcinoma (is_implicated_in) | 1.80e-03 | 16 | 117 | 2 | DOID:3587 (is_implicated_in) | |
| Disease | Microangiopathy, Diabetic | 1.80e-03 | 16 | 117 | 2 | C0025945 | |
| Disease | Global developmental delay | 1.97e-03 | 133 | 117 | 4 | C0557874 | |
| Disease | Benign neoplasm of stomach | 2.04e-03 | 17 | 117 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 2.04e-03 | 17 | 117 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 2.04e-03 | 17 | 117 | 2 | C0154060 | |
| Disease | smoking behavior | 2.44e-03 | 341 | 117 | 6 | EFO_0004318 | |
| Disease | cataract | 2.44e-03 | 141 | 117 | 4 | MONDO_0005129 | |
| Disease | Alzheimer disease, age at onset | 2.51e-03 | 343 | 117 | 6 | EFO_0004847, MONDO_0004975 | |
| Disease | skin sensitivity to sun | 2.55e-03 | 19 | 117 | 2 | EFO_0004795 | |
| Disease | BMI-adjusted waist-hip ratio, physical activity measurement | 2.63e-03 | 69 | 117 | 3 | EFO_0007788, EFO_0008002 | |
| Disease | cortical surface area measurement | LEO1 SRPK2 NCKAP5 CHD7 STOX1 STRIP1 BMP6 THBS1 GLI3 RP1L1 RERE PARD3 RHOT1 | 2.64e-03 | 1345 | 117 | 13 | EFO_0010736 |
| Disease | chemokine (C-C motif) ligand 27 measurement | 2.74e-03 | 70 | 117 | 3 | EFO_0008082 | |
| Disease | adiponectin measurement | 2.77e-03 | 146 | 117 | 4 | EFO_0004502 | |
| Disease | Endometrial Carcinoma | 2.97e-03 | 72 | 117 | 3 | C0476089 | |
| Disease | asthma | 3.07e-03 | 751 | 117 | 9 | MONDO_0004979 | |
| Disease | Stomach Carcinoma | 3.12e-03 | 21 | 117 | 2 | C0699791 | |
| Disease | osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty | 3.12e-03 | 21 | 117 | 2 | EFO_0004616, EFO_0010726, EFO_1000786 | |
| Disease | nucleus accumbens volume | 3.42e-03 | 22 | 117 | 2 | EFO_0006931 | |
| Disease | Corneal astigmatism | 3.59e-03 | 77 | 117 | 3 | EFO_1002040 | |
| Disease | vital capacity | CLUAP1 IPO8 VTA1 CHD7 IRX1 BMP6 THBS1 THBS2 DST GLI3 SMARCA2 PARD3 | 3.72e-03 | 1236 | 117 | 12 | EFO_0004312 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EDANSEKSINEENGE | 16 | Q13523 | |
| GGDSQEESELDDQEE | 1221 | Q7Z7A1 | |
| STENGEEEEEQSECQ | 4416 | Q9NR09 | |
| DDNKDSAAFEDNEVQ | 711 | Q9UIG0 | |
| SQVNESDADDEDNYG | 4871 | Q6V0I7 | |
| LESDELQAQQEDSDE | 916 | Q5JTC6 | |
| DEEVLQGEQGDFNDD | 761 | Q9NSY1 | |
| LENGSSDEEAEEEEN | 456 | Q14692 | |
| LDSLDGGDEIENNEN | 2981 | Q9P2D1 | |
| AAEEEQEGDSGEQET | 421 | Q96KC8 | |
| DGSDDEEESQDIVNQ | 151 | Q9UQN3 | |
| NEDDEEDVVDLAANS | 51 | Q9UHL0 | |
| ELNDDLLQSDNEDEE | 66 | Q96EV2 | |
| EEQQGAEEEEDGAAS | 261 | Q8IVL6 | |
| EAGLDAEAEQNEEDE | 391 | P48544 | |
| EENTNAIDGAGEEAD | 876 | Q9P2P5 | |
| ELEEDDNNENAGEDG | 1436 | Q9Y4B6 | |
| DDVNEDQGDDQLELI | 256 | O60812 | |
| DDDEDGQDNQGTVTE | 161 | Q86U86 | |
| NSDDEERAQGSDEDK | 161 | Q8WVC0 | |
| ALDALNTDDENDEEE | 261 | P55081 | |
| NLDSEDKNGGEDTDN | 4886 | Q9NU22 | |
| DADANLNDEDFLPDD | 1081 | P10071 | |
| DAEEGEDNRDSTNGQ | 276 | B2RXH8 | |
| NENLVENGADSDEDD | 676 | Q9UHB6 | |
| LDDQDTCGIDGDNEE | 16 | O60551 | |
| EDDSGEGEDDAEVQQ | 31 | Q8IXH7 | |
| IESEGDENENDQDSL | 66 | A8MXD5 | |
| EDQGDDQLNVFGEDT | 351 | Q9Y6K8 | |
| LASDNEEEEDEKGNS | 2926 | O95714 | |
| QSEQELENLEAGADD | 3941 | Q03001 | |
| DDDNEDQGDNQLELI | 256 | B7ZW38 | |
| LEGQDENQEGDFEDA | 71 | Q96A33 | |
| ENQEGDFEDADTQEG | 76 | Q96A33 | |
| DEILSDDNFNLENAE | 881 | Q6ZWH5 | |
| SDQDNDGTLNDAELN | 196 | Q8IXI2 | |
| NEEEDDAGVEDAADA | 236 | O60337 | |
| GVDTQNSEGNADEED | 341 | Q8ND56 | |
| AENEQDEQDENGAEA | 476 | P26038 | |
| DEQDENGAEASADLR | 481 | P26038 | |
| DENSNPDLSGDENDD | 26 | O75530 | |
| DDDNEDQGDNQLELI | 256 | P0DMR1 | |
| VGNSDEDEEQDDKNE | 46 | Q8WVL7 | |
| QKAGGAEDEQENEDD | 1941 | Q07864 | |
| QTDDLGDNDGAEDED | 191 | Q8N2Q7 | |
| EASDDAVQGQDLDED | 211 | Q86VP3 | |
| SNQAGSSQDEEDDDD | 161 | Q01658 | |
| SDEDENDEGNDEDHS | 246 | O94880 | |
| DDVVAEAGNETENEN | 401 | Q9HC58 | |
| EAGNETENENEDNEN | 406 | Q9HC58 | |
| ADDPNNQGEDEFEEA | 551 | O00461 | |
| NAEETYGENDENTDD | 636 | O00461 | |
| SDKENDQEHDESDNE | 331 | Q9BZF1 | |
| EEDAAAETAQNDDHD | 1301 | Q92794 | |
| EDDADSDDEDRGQAQ | 461 | Q8N7H5 | |
| KSEQDQAENEGEDSA | 531 | Q99613 | |
| DTEQIAEEGDDNLAN | 476 | Q9Y2I7 | |
| EEEDNDEEAAAGSRA | 141 | Q96GS4 | |
| QDTDDEDEEDQSSGA | 446 | Q8TAL5 | |
| SVDEDSSGNQEEQEE | 86 | Q969H0 | |
| QRKNQDDDDDDDDGF | 76 | Q8IXQ4 | |
| DNDEDGASEGERQQS | 146 | P22004 | |
| ELSNTSENDEQNAED | 1271 | Q9NSI6 | |
| SENDEQNAEDLDDSD | 1276 | Q9NSI6 | |
| ADNNIDANEETLETD | 341 | Q6VMQ6 | |
| IVISDDDNDDDNGND | 121 | Q96QF7 | |
| DNGNDLEVPDDNSDD | 131 | Q96QF7 | |
| DQGAEAADNQREEAA | 326 | Q9H0W5 | |
| EGAEAADNQREEAAD | 351 | Q9H0W5 | |
| AEENNDINIETDNDS | 456 | Q9BY12 | |
| EREAANEAGDSSQDE | 151 | Q9NVU0 | |
| NEAGDSSQDEAEDDV | 156 | Q9NVU0 | |
| DESGENEEEAGLENS | 476 | P54277 | |
| GNTDTQADEDERAQE | 1306 | P30622 | |
| DEEDEDNTSEAENGF | 26 | Q03701 | |
| EDNQDDDSDLLQDLS | 566 | Q6PJW8 | |
| QEQDEDGTEEDNSRV | 236 | Q8TEW0 | |
| QSNNGRGEDEEEEDD | 916 | O15397 | |
| DLNADDFSSQDNLDD | 1176 | Q9NQT8 | |
| NVNENGEGEIEDEEE | 46 | Q9BRS2 | |
| VSSDNEDDDDEEDGN | 281 | Q12872 | |
| AEEDNQEEGESEAEG | 141 | Q96DX7 | |
| DNIDDDDGDNDHEAL | 311 | O94763 | |
| DQELDAQSLDDEDDN | 316 | Q9P270 | |
| DSDEEQDEREQSEGS | 1571 | P51531 | |
| EANENLQEDEDDAVA | 1686 | O14513 | |
| NEELNEDDSQSDEKD | 1096 | P35251 | |
| DKIDEHDGDQSNEDD | 231 | P78414 | |
| HDGDQSNEDDEDKAE | 236 | P78414 | |
| TDDQEEDEENSLGTE | 1056 | Q14524 | |
| EEEENDDDNSLEGET | 381 | Q5VSL9 | |
| QEAAAAEGAQKEDNE | 231 | Q8IUH8 | |
| EEETSNEGENNEESN | 81 | P21815 | |
| NEGENNEESNEDEDS | 86 | P21815 | |
| ENEESEAEVDENEQG | 161 | P21815 | |
| EEDNVEQSGEEEAEA | 1041 | Q93073 | |
| VNRDDQEQDALGSDA | 1176 | Q5T8A7 | |
| GLDDLENAEEEGQEN | 21 | P61218 | |
| SEDEDNDNNSATAEE | 56 | Q9P2R6 | |
| SQSQADEEEEDDDFG | 536 | Q6ZRS2 | |
| ESDIDQNQSDDGDTE | 841 | Q13972 | |
| NGSVADCVEDDDADN | 141 | Q15424 | |
| DCVEDDDADNLQESL | 146 | Q15424 | |
| NTQEDAADGEQREEE | 636 | Q0VD83 | |
| EENDNDNESDHDEAD | 116 | Q9NRG0 | |
| NDDSDIDIQEDDESD | 311 | Q96AJ1 | |
| QGNLKGFINDDDDED | 51 | Q7KZ85 | |
| ADTQDDDVEEIGDQD | 156 | O43829 | |
| RIGDTCDNNQDIDED | 851 | P07996 | |
| EAQIGQEAQDEDSSD | 3271 | Q8IZQ1 | |
| EGAEAQEAEEAAQEA | 1936 | Q8IWN7 | |
| ESEDVDAQEAEGEAQ | 2081 | Q8IWN7 | |
| QDATANDGEEAFEDE | 426 | Q9BUF5 | |
| EQDDDNNSADGQQED | 836 | Q8N3U4 | |
| EDNDIEENEDAGAAS | 171 | Q9NP79 | |
| DDQALYQNEVEDDDG | 716 | Q6ZVD7 | |
| EDSSDEDDKRNQGNL | 496 | Q8TCJ2 | |
| KNEAEGADDLQANEE | 131 | Q7Z699 | |
| VINAADDDEDDDDQF | 156 | O75152 | |
| AETAKDNGEAEDQEE | 336 | P78362 | |
| IVFNDNDGSDDENDD | 646 | O60281 | |
| SDEDSNDNDNDIENE | 961 | Q9Y4E8 | |
| DQDNQDDSSDDGFLA | 936 | Q9GZR1 | |
| SEDELAFGENDNREN | 326 | O15060 | |
| VINAADDDEDDDDQF | 156 | A0A1B0GTU1 | |
| EENADSDDEGELQDL | 346 | Q96NB3 | |
| NDLVGDQCDNNEDID | 851 | P35442 | |
| DQCDNNEDIDDDGHQ | 856 | P35442 | |
| NDINAAGESEELANE | 606 | Q7Z2W7 | |
| LNENQASEEEDELGE | 96 | Q9UD71 | |
| NEENGEQEADNEVDE | 41 | P06454 | |
| EEGSKADVNAQDNED | 221 | Q59H18 | |
| ALEQLDEQDGDAEQS | 606 | Q86UV5 | |
| ELEDGEISDDDNNSQ | 21 | O60293 | |
| VALDNEDEEQEASQE | 591 | Q6EMB2 | |
| DAQCSQNENDEDSDG | 351 | A8MT70 | |
| QNENDEDSDGEETKV | 356 | A8MT70 | |
| NNLLSRDDEDGDDGD | 221 | O95071 | |
| DNEDSEHENDDDTNQ | 1986 | O95071 | |
| SIEEEQEQEEDGGSQ | 291 | Q9NR99 |